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Introduction 
11.0 INTRODUCTION 
11.1 General 
Proteinase binding a-macrogiobuiins (aMs) constitute a large group of 
glycoproteins that occur in the blood and other body fluids of nearly all the studied 
vertebrates, in the egg whites of reptiles and birds as well as in few higher invertebrates 
(Sottrup-Jensen, 1989). The aMs should ideally be considered sophisticated binding 
proteins activated by proteolysis. The aM super family that also includes complement 
C3, C4 and C5 (Sottrup-Jensen, 1987; Dodds and Day, 1993) is characterized by the 
ability of its members to interfere with the action of all the four classes of 
endoproteinases thiol, serine, acid and metalloproteinases and usually by: 
1. The presence of a particularly exposed stretch of amino acids termed bait region. 
2. Ability to undergo conformational change on proteolysis at the bait region and 
bind the attacking proteinases. 
3. Ability to shield the bound proteinase(s) from large molecular weight 
inhibitors/substrates, while retaining access towards those of smaller dimensions. 
4. Occurrence of a protected internal P-cysteinyl-y-glutamyl thiol ester linkage with 
a potential for covalent binding of the activating proteinases and nucleophiles. 
5. Ability to expose an unexposed site on proteolysis that is recognised by the high 
affinity receptors present on several cell types. 
aMs have attracted remarkable attention in view of their implication in a variety 
of biological iiinctions including restricting proteolysis, functioning as back-up 
proteinase inhibitors, clearing of proteinases from circulation, modulating immune 
response and binding several hormones, growth factors, etc. Specific expression of some 
aMs under conditions like infection or pregnancy further reteriate their important role in 
vivo. Extensive investigations have been made on the structure, proteinase and 
nucleophile-induced alterations, behaviour under stress and disease of various aMs 
(Roberts, 1986; Sottrup-Jensen, 1989). 
aMs have been identified in a large number of animal species and isolated, 
purified and characterised from several sources. While the amino acid sequence analysis 
suggest that proteins of the aM family are quite conserved, occurrence of interesting 
variations in molecular dimensions, quaternary structure, sensitivity towards proteinases 
and amines as well as in proteinase entrapment efficiencies in the inhibitor from a variety 
of animal sources suggest remarkable evolutionary adaptations. Work on human aMs 
has been reviewed extensively (Sottrup-Jensen, 1987; 1989; Chaudhari, 1993). Attempts 
have therefore been made to present a critical account of aMs primarily from animal 
sjpecies. 
1.2 Structure of aMs 
1.2.1 Molecular structure 
The structure of human, several other vertebrate and few invertebrate aMs has 
been elucidated in remarkable details at all levels. Majority of the characterised aMs are 
tetrameric, comprising of identical subunits assembled as non-covalently associated 
dimers of two disulphide-bonded dimers. Reports of heterotetrameric, homodimeric, 
heterodimeric and monomeric aMs are also however available (Table 1.1). 
It has been suggested that aMs, both proteinase inhibitors and complement 
components, have evolved from a common monomeric precursor (Sottrup-Jensen et al, 
1985). Starkey and Barrett (1982) hypothesized earlier that mam;Tialian murinoglubulin 
(MUG) and non-mammalian monomeric aMs evolved directly from a common ancestral 
gene based on the general features of molecular evolution: the primitive gene emerges as 
a monomer, and then evolves into polymer with concomitant development of additional 
function. Surprisingly, monomeric a2Ms have not been identified in non vertebrate and 
presumably amphibian represent the most primitive class in which they have been 
identified while their occurrence jn rodents has been reported by several investigators, 
irhis suggest that the MUG is not a primitive form of tetrameric aM but rather has 
evolved under selective pressure which is different from that of the tetrameric paralogue 
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(Iwasaki et al., 1996). They appear to be widespread among aves, reptiles, amphibia and 
mammals (Rubenstien et al., 1993; Miyake et al., 1993). Rat aib is a structurally and 
functionally well characterized monomeric proteinase inhibitor, comprising of single 
ix)lypeptide of 180 KDa. (Enghild et al, 1989). 
aMs appearing in the hemolymph of the invertebrate limulus belonging to the 
£u-achnid class is homodimeric (Spycher et al, 1987), so are those of the other 
invertebrates such as horseshoe crab (Quigley and Armstrong, 1983a;b), octopus 
(Thogersen et al, 1992), crayfish (Hergenhahn et al, 1988; Stocker et al, 1991). 
Homodimeric aMs have also been characterised from several mammalian and avian 
sources (Sottrup-Jensen, 1987) and include PZP of humans (Sand et ah, 1985; 
Christensen et al, 1989), hag fish a2M (Osada et al, 1988), frog a2M (Feldman and 
Pizzo, 1986) and crocodile ovostatin (Ikai et al, 1985). Plaice aM is however 
heterodimeric comprising of disulphide linked 105KDa and 90 KDa peptides (Starkey 
and Barrett, 1982). 
Starkey (1983) categorised the tetrameric aMs into type I and type II based on 
the nature of subunits. While type I aMs are composed of identical subunits, those with 
non identical subunits were grouped as type II. Human aMs, and those from rabbit 
(Lebreton de Vonne and Mouray, 1968), horse (Motoshima et al, 1988), guinea pig 
(Suzuki and Sinohara, 1986a;b), cow (Nagawsa et al, 1970), dog (Ohlsson, 1971a;b\ 
chicken (Feldman and Pizzo, 1984a) and duck (Nagase et al, 1986) are homotetrameric 
and hence of type I. 
Mouse a2M (Hudson, 1987) and rat aiM (Schaeufele and Koo, 1982) are type 11 
inhibitors, have basic architecture similar to human a2M but the quarter subunits are 
made up of two unequal disulphide linked polypeptides chain. The mouse a2M 
comprises of four heavy (163 KDa) and four light chains (35 KDa) while heavy and light 
chain in rat aiM are of 140 KDa and 42 KDa (Hudson et al, 1987; Longberg-Holm et 
al., 1987). The proposed model for human and mouse a2M representing type I and II 
aMs (Harpel, 1973; Steinbuch et al, 1975; Barrett et al, 1979; Hudson et al. 1987) are 
shown in Fig. 1.1. 
Starkey and Barrett (1982) proposed that the single chain subunits otM 
homologues probably arose from ancestral protein having subunits of unequal sizes by 
one of the two mechanism. The first assumption that the structural genes for subunit I 
and II of aM are adjacent and that deletion of the stop sequence between these two genes 
resulted in their being transcribed as single m-RNA and is translated as single 
polypeptide corresponding to quarter subunit of a2M. The second hypothesis suggests 
that aM homologue having larger and smaller subunit originally arose from single c h ^ 
precursor by post translational cleavage by specific proteinase . A mutation in the amitK) 
acid sequence recognised by the specific proteinase could then give rise to a precursor 
protein that was resistant to proteolysis and persisted as 185 KDa subunit. Such post 
trannslational proteolytic processing has been proved in rat aiM (Geiger et al., 1987). 
In the course of an experiment to isolate aM, murine plasma was shown to 
contain two different components having trypsin-protein esterase activity. The isolation 
and characterization of the two components revealed that one was previously known aM 
(Greene et al, 1971; Hudson and Koo, 1982), whereas the other, tentatively named 
MUG, did not correspond to any of the known proteinase inhibitors in the mammalian 
plasmas. MUG clearly differed from mouse aM and human a2M in antigenicity, 
molecular size and binding properties with trypsin, papain and thermolysin. (Saito and 
Sinohara, 1985 a). 
MUG have been purified and characterised from the plasma of several other 
rodents such as guinea pig (Iwasakai et al, 1996), rat (Saito and Sinohara, 1985 b) and 
hamster (Miyake et al, 1993) and are characterised chemically and physiochemically. 
Rat plasma protein named ai-inhibitor 3(ail3) (Gauthier and Ohlsson, 1978) was thought 
Figure J ,1 Proposed model for the structure of human (A) and mouse (B) a2M. 
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to be the rat counterpart of human inter-a-trypsin inhibitor, since they showed 
immunological cross reactivity (Esnard and Gauthier, 1980; Esnard et al, 1985). 
However, it wafi later identified as a monomeric aM (Esnard et al, 1985) that is a 
mixture of two isoforms, MUG I and MUG II (Saito and Sinohara, 1985a). MUGs have 
not however been detected so far in rabbit, dog, sheep, bovine, goat, pig or human (Saito 
and Sinohara, 1985a). 
Complete amino acid sequence of the tetrameric human a2M, rat a2M, aiM, 
dimeric human PZP and monomeric aJa are available (Sottmp-Jensen et al, 1984; Kan 
et al, 1985; Aiello et al, 1988; Eggersten and Fey, 1989). A comparison of these 
sequences of the a2Ms indicates that 41% of all residues are conserved which suggests 
that the three dimensional structures of aM subunits of the tetrameric, dimeric and 
monomeric fonris may be similar. Lack of remarkable internal sequence similarities are 
also characteristic although a repeating pattern of predicted p-strands and turns 
throughout the sequence of human aaM suggests a multiple domain structure largely 
composed of rather long p-barrel type domains. Sequences of the genes coding human 
and rata2M, and rat a\h are also available (Sottrup-Jensen, 1987 ; Eggersten et A/.,1991; 
Kane^a/.,1985). 
1.2.2 The bait region 
The bait region of aMs comprises of an exposed stretch of amino acids located 
approximately in the middle of the monomer that provides peptide bonds susceptible to 
cleavage by all classes of proteinases (Fig. 1.2). The aM bait region appears to be 
imiquely positioned in a manner that enables the adoption by the segment of a 
conformation that facilitates ready access to a wide variety of proteinases (Sottrup-
JFensen, 1987; Sottrup-Jensen et al, 1989). The bait region appears to be an irregular 
solvent exposed flexible structure (Sottrup-Jensen., 1989) and paramagnetic resonance of 
l3ie human a2M indicates that it is a relatively compact (Gettins et al, 1988). 
Figure !.2 .ScheJiiulic diagram oi' human a:;M subunit showing relative positions 
of thii lunctionaJh' important regions. 
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The bait region in human ajM may be located very close (11-17°A) to the thiol 
ester bond (Gettins et al. 1988) or positioned 20-25°A away and may form a compact 
loop of two strands of P-sheets (Sottrup-Jensen et al, 1990). 
Remarkable variations between the length, composition and sequence of the bait 
regions of a2M have been observed in various animal species, inspite of its apparent 
identical function. Thus, while the bait region of human a2M is 39 amino acid long (Kan 
et al, 1985; Sottrup-Jensen et al, 1986), those of human PZP, rat aiM, rat a2M and aih 
have respectively 49, 53, 52 and 32. residues (Sottrup-Jensen et al., 1984; Sand et al, 
1985; Gehring et al. 1987; Aiello et al. 1988; Braciak et al. 1988). 
Over half the amino acid residues of the bait regions of aMs are hydrophobic 
(Kyte and Doolittle, 1982) but they are also generally rich in charged residues. The 
number of charged residues in the bait region is 9 in human a2M, 6 in rat aiM, 8 in rat 
a2M, and 12 and 13 respectively in variants 1 and 2 of rat aib (Sottrup-Jensen et al, 
1989). Human PZP with only three charged residues in the bait region appears to be an 
exception (Sottrup-Jensen et al, 1984; Sand et al, 1985). Glycine and proline residues 
appear generally abundant in the bait regions although those of rat a2M and aib have 
relatively lower content of the amino acids. (Sottrup-Jensen et al. 1989). Considering 
the marked diversity in the amino acid composition/sequence it is not clear if the bait 
region of all aMs have similar conformations. 
Inspite of the susceptibility of a wide variety of proteinases to inhibition and 
complex formation by the aMs, their rates of interaction with the inhibitor differ 
remarkably. For instance, while the rates of cleavage of human a2M, rat aiM and a2M 
by the restrictive human fibroblast collagenase are high, those of rat aila and human PZP 
are very low (Sottrup-Jensen, 1989). Rat aiM shares 57.2 and 53 percent overall amino 
acid sequence identity with a2M and ails respectively yet they differ, remarkably in the 
sequence of the bait region (Eggertsen et al, 1991). This suggests that in vivo each 
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inhibitor may actually address a specific of proteinases. Infact, the chicken ovostatin may 
be specific for metalloproteinases and the duck ovostatin for serine and 
metalloproteinases (Nagase et a!.. 1986; Feldman and Pizzo, 1984a). 
The bait region, apart from serving as a site for proteolysis for target proteinases 
also plays an important role in the non-covalent association of the half molecules into 
active tetrameric a2M. A part of the C-terminal portion may be actually involved in the 
non covalent association of a2M dimers into active tetramers (Gettins et al., 1995). 
Perhaps relevant to the role of the bait region in interdimeric interactions is the 
observation that it is much harder to disrupt the non covalent interaction in the proteinase 
reacted aiM, than in native a2M. This suggest a major alteration in the interdimeric 
contacts on the proteolysis of the bait region (Pochon et ah, 1989; Pochon et al., 1987). 
More recent findings by Gettins et al. (1995) implicate the bait region in the 
conformational changes that results in thiol ester activation and proteinase trapping. 
Novel inhibitory specificities not exhibited by the native aMs have also been 
introduced in the inhibitor using recombinant DNA technology. Van Rompaey et al. 
(1995) obtained a recombinant of human a2M (ra2M ) by introducing of a heptapeptide 
(Glu-Asn-Leu-Tyr-Phe-Gln-Gly)in the bait region. Unlike the unmodified inhibitor the 
ra2M exhibited significant inhibitory action toward the tobacco etch virus (TEV) 
proteinase. In a more recent study Van Rampaey et al. (1997) created a human a2M that 
was inhibitory towards a membrane bound proteinase which was recalcitrant to the action 
of the native a2M. 
1.2.3 The thiol ester 
aMs and the complement proteins C3 and C4 are presumably the only known 
proteins that contain an internal thiol ester linkage (Sottrup-Jensen, 1987). The thiol ester 
appears to serve two important ftlnctions - to provide means of covalent binding to target 
proteinases and other proteins and mediate the large scale conformational rearrangements 
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that accounts for the engulfing of the challenging proteinases in the oligomeric form even 
in the absence of covalent binding (Gettins et al., 1995). 
In human a2M, the thiol ester forms a 15 membered thiolactone ring involving the 
conserved segments Cys949-Gly-Glu-Glx952 (Tack et al, 1980; Harrison et al, 1981; 
Sottrup-Jensen et al, 1985). The thiol ester is located in a small hydrophobic pocket 
shielded from the solvent and is accessible only to small molecular weight nucleophiles 
such as ammonium ion, methylamine and hydroxylamine (Gettins et al, 1988; Larson et 
al, 1987; Zhao et al, 1988). Similar nucleophilic attack by the amino group at of the y-
carbonyl group of glutamic acid residue cleaves the peptide at this site at elevated 
temperature (Fig. 1.3.) (Barrett et al, 1979; Harpel et al, 1979; Howard, 1981). Bait 
region cleavage of monomeric and oligomeric aMs by proteinases however remarkably 
increases the reactivity of the thiol ester transforming it into a short lived nascent state in 
which it reacts to form a e-lysyl-y-glutamyl bond with a variety of nucleophiles including 
the side chain amino groups of the attacking proteinases (Fig. 1.4) or other proteins 
(Sottrup-Jensen, 1989; Borth and Luger, 1989; Ghetie et al, 1991). In addition, several 
growth factors have been shown to be" associated to aMs via the thiol ester linkage 
(Feige, 1996; Lysiak, 1995; Web, 1995). It has also been shown recently that covalent 
complexes formed between aMs and protein may facilitate antigen presentation by 
macrophages to the T-cells (Chu et a/., 1994; Chu and Pizzo,1993). Formation of the 
covalent linkage however appears to be obligatory for the formation of inhibitor-
proteinases complex only in case of the monomeric and possibly some dimeri.c forms 
(Saito and Sinohara, 1985a;b; Sottrup-Jensen, 1989; Longberg-Holm etal, 1987). 
Reaction of the thiol ester of himian a2M with the small nucleophiles results in a 
major conformational change in the molecule leading to the formation of a 
electrophoretically fast form which resembles that induced by the proteolytic attack on 
the bait region and accompanying cleavage of the thiol ester. Subtle difference between 
the fast forms resulting from methylamine treatment and bait region cleavage have 
however been observed (Delain et al, 1988). 
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Figure 1.3 The sdnicfure of the thiolester bond loop in ajM and reaction of 
amines with aiM (up{)er reactions) and heat/alkali induced cleavage 
of the siibunit chain (lower reactions). 
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Figure 1.4 Formaiicin of covalent bond between a2M and proteinase by the 
thiolesltr bond loop. 
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The thiol esters of aMs and the complement proteins are located in the highly 
conserved regions of the molecule (Tack et al., 1980; Campbell et al, 1984; Sottrup-
lensen et al, 1984). Remarkable differences however exist between the reactivities of 
thiol esters and their function in aMs of different animal species (Table 1.2), thus the 
access of the thiol ester in mouse and rabbit inhibitor is low and only limited 
conformational change occurs in murine a2M in presence of methylamine (Tamamizu et 
al, 1989; Saito and Sinohara, 1985 a). The thiol esters of rabbit a2M are less sensitive to 
methylamine and require very high concentration of the nucleophile for the cleavage of 
all the four thiol esters. Even in the fully reacted state the inhibitor retains about half of 
its capacity to inhibit trypsin (Tamamizu et al, 1989). Similarly bovine aaM (Bjork et 
al, 1985), rat a2M(Goniase/fl/., 1983)and equine a2M(Motoshimae/a/., 1988), exhibit 
only small or no increase in electrophoretic mobility and retain significant proteinase 
inhibitory activity on methylamine treatment. There exist a marked difference between 
the human and bovine proteins in amino acid residue side chain size and charge close to 
thioester bonds. These differences may explain the greater conformational stability of 
bovine a2M, subsequent to the cleavage of the thiolester bonds as compared with human 
a2M (Bjork and Jomvall, 1986). Other examples of a2Ms exhibiting comparable 
sensitivity to methylamine and exhibiting similar alterations in electrophoretic mobility 
and proteinase inhibition as human a2M are available in (Tables 1.1 and 1.2). 
Green turtle a2M is unique in that it undergoes polymerization via intemolecular 
disulphide formation involving sulphydryls released as a result of cleavage of the thiol 
esters (Osada e/a/., 1988). 
The thiol esters of most aMs exposed to small nucleophiles or proteinases have 
been considered as "pseudoenzymatic sites "turning over once for all (Sottrup-Jensen, 
1987). Pangbum (1992) have however shown that ammonia inactivated a2Ms, 
complement C3 and C4 regain the thiol esters to a limited extent after removal of excess 
ammonia. In a more recent study, Gron et al (1996) have shown that ammonia or 
methylamine induced cleavage of the thiol ester can be reversed at high temperature, and 
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used the procedure to entrap proteins in a2M without bait region cleavage. Bhattachaijee 
et al. (1999) have demonstrated that under appropriate conditions, mouse aiM is fully 
converted to the fast form by NH3 despite of the aforementioned structural differences 
between human and mouse a2M. Thus both molecules are able to incorporate non 
proteolytic ligands in a similar manner. Ligands incorporated in this manner also 
demonstrate an enhanced immune response relative to the free ligand. 
Inspite of the apparently important role played the proteinases inhibitory property 
of aMs may not be dependent upon thiol esters per se but on their ability to contribute to 
the characteristics conformation of aMs. Thus while the duck and crocodile ovostatin 
have conserved characteristic thiol esters, (Nagase, 1986; Ikai et al, 1983) chicken 
ovomacroglobulin is unique in not containing any (Nagase and Harris, 1983). 
Surprisingly, however the chicken ovomacroglobulin also undergoes the characteristic 
proteinases induced "slow" to "fast" transformation (Nagase and Harris, 1983). Other 
aspects of structure and the mechanism of proteinase inhibition of the egg white protein 
ovostatin (ovomacroglobulin) are similar to those of plasma a2M (Feldman and Pizzo, 
1984a). 
In order to determine the precise role of the thiol esters, Gettins et al. (1994) 
obtained a recombinant variant of a2M, C949S, expressed in baby hamster kidney cells 
that lacked the thiol ester forming cysteine. C949S a2M behaves like methylamine 
treated plasma a2M with correctly formed inter-subunit disulphide bridges, but the 
molecule had exposed receptor recognition site and lacked the ability to inhibit 
proteinases. Thus correct folding of monomers and their association to the tetrameric 
form does not require pre-formed thiol esters. 
1.2.4 aM receptor/receptor recognition site 
The receptor recognition site is one of the three major sites (others are bait region 
and thiol ester) essential for physiological function of aMs. The aMs attacked by 
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proteinase(s) or by small nucleophiles such as methylamine undergo a major 
conformational change resulting in the exposure of a specific receptor recognition site 
and in the appearance of new antigenic sites, specifically recognized by a monoclonal 
antibody raised by Marynen et al. (1981). Studies of Sottrup-Jensen et al. (1985) have 
shown that the domain bearing the receptor recognition site in human a2M is also present 
in complement C3 and C4 (Van-Leuven et al, 1986). 
The receptor recognition site has been shown to be a part of the proteolytically 
derived carboxy terminal 20 KDa fragment of human a2M (Sottrup-Jensen et al., 1986; 
Van Leuven et al, 1986a;b). Homologous carboxyl-terminal fragments can also be 
obtained from the tetrameric human a2M, bovine a2M and rat aiM and a monomeric rat 
ctils (Enghild et al, 1989). The C-terminal fragments bind to a2M receptors on 
p>eritoneal macrophages and other cells. (Enghild et al, 1989). The low binding affinity 
of 20 KDa fragment towards the a2M receptor however suggests that the fragment may 
not represent the complete receptor recognition site and believed to be a part of a larger 
40 kDa C-terminal structural domain (Gordan, 1976; Enghild et al, 1989; Rubenstein et 
al, 1991; Thomson and Sottrup-Jensen, 1993). 
Both human and bovine a2Ms shows glycosylation at Asn''* '^ (Enghild et al, 
1989) 20 KDa fragments. Glycosylation at Asn , is seen in bovine but not in the 
human inhibitor. The overall amino acid sequence identity between the carboxyl 
terminal 20 kDa domain of human a2M, bovine a2M, rat aih and aiM was about 75% 
(Enghild et al, 1989). Occurrence of two segments of extraordinarily high identity 
corresponding to residues 1359-1376 and 1424-1435 of the human a2M sequence 
suggests that the primary receptor recognition domain may be located in one or both of 
these region. There exists a Cys'^^' - Cys'*^ disulphide bridge in the receptor binding 
domain of human a2M which is conserved in bovine a2M and rat ails but not in rat aiM 
(Enghild et al, 1989). The interchain disulphide bond is required for binding of the 
human a2M carboxyl terminal 20kDa fragment to the receptor (Sottrup-Jensen et ah. 
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1986). In the 20kDa fragment of the human a2M, this bond, is thought to be necessary to 
maintain the conformation around the primary receptor recognition site. Enghild et al. 
(1989) proposed that in rat ajM two phenylalanine residue which substitute for Cys'^^' 
and Cys'''** may stack, and thus stabilize a conformation in the inhibitor in absence of the 
disulphides. 
The level of circulating aM-proteinase complexes is very low as a result of their 
rapid clearance primarily by the receptors on hepatocytes (Travis and Salvesen, 1993; 
Tapon-Bretaudiere et al, 1985; Spolarics et al, 1985). The in vivo half life of the 
complexes is 2-5 mins and they bind with high affinity (Kd = 10'* - 10"'° M) to an 
endocytosing receptor known as a2M receptor / low density lipoprotein receptor related 
protein (a2MRA>RP) (Van-Leuven et al, 1986). The receptors have been identified on 
fibroblast cells like, monocytes / macrophages and syncytiotrophoblasts (Tapon-
Bretaudiere et al, 1985; Van-Leuven et al, 1986, Sottrup-Jensen et al, 1986, Pizzo, 
1988; Jensen era/.. 1988). 
The Kd of human and bovine receptor binding domain to a2MR/LRP (-60-125 
nM) in different systems (Van Leuven et al, 1988; Sottrup-Jensen et al, 1986; Enghild et 
al, 1989) is greater than the Kd for binding a2M-methylamine (~ 40 pM and 2 nM for 
tte high and low affinity binding respectively) (Moestrup and Gliemann, 1991). 
Tterefore, it has been questioned whether receptor binding domain in its structure 
contains all information necessary for receptor recognition by a2N' (Enghild et al, 1989; 
Gliemann et al, 1995). However, the finding that human receptor binding domain 
variant (RBDv), which contains 12 additional upstream residues, binds to a2MR/LRP 
with a Kd of ~8 nM indicates that C-terminal fragment may indeed constitute the receptor 
binding domain of a2M, but its conformation may be subtly affected by neighbouring 
residues (Hotlet et al, 1994). Receptor binding may principally involve only one 
receptor recognition domain and is Ca^ ^ dependent. (Gliemann and Sottrup-Jensen, 
1987). The sequence of internalization and degradation of aM-proteinase complexes 
may be analogous with that of the low density lipoprotein (Gliemann et al., 1989). 
Functionally active aiM receptor (a2MR) has been purified from human placenta, 
rat hepatocytes and human fibroblasts (Aschom el al, 1990; Jensen and Pizzo, 1989). 
Tlie receptors do not discriminate among various rnanmialian otMs (Sottrup-Jensen, 
1987; Gliemann and Sottrup-Jensen, 1987). However that the mammalian receptors do 
not recognize the ovostatins (Feldman and Pizzo, 1984b). Sequence analysis of purified 
human placental a2M receptor indicates that it is identical to LRP (Strickland et al, 
1990; Kristensen et al, 1990; Jensen et al., 1989). This receptor is of a classic scavenger 
type with a single membrane-spanning domain that binds a variety of ligands including 
the Pseudomonas exotoxin A, plasminogen activator, lactoferrin and lipoprotein lipase 
{Koumas et al, 1992; Nykjaere/fl/., 1993; Orthe/o/., \992;hu et al, 1992; ChappeU/ 
al, 1992; Willnow et al, 1992). These ligands do not normally compete with each other 
for binding to LRP/a2MR, presumably because they are recognized by independent sites 
(Krieger and Herz, 1994). 
Misra et al (1993) identified a second a2M receptor, a G-protein coupled a2M 
receptor, distinct from the LRP/a2M receptor. On ligation this receptor induces a 
signalling cascade resulting in the production of myo-inositol 1,4,5-triphosphate (IP3) 
and an increase in intracellular Ca and cyclic AMP. Ligation of a2M-methylamine 
(a2M-MeNH2) or receptor binding fragment (RBF) from rat aiM induces 
phosphorylation of a number of proteins including phospholipase Cyl (Misra et al, 
1994; 1995). 
The binding of human a2M-methylamine to its receptors on macrophages has also 
been shown to regulate tumour kill, the respiratory bursts, prostaglandin synthesis and 
secretion of proteinases (Johnson e/flf/., 1982;Hofmanne/a/., 1983; Uhingf/a/., 1991). 
During the proteinase attack on the inhibitor, a2M can incorporate antigens and augment 
macrophage-dependent antigen presentation to T-cells (Chu and Pizzo, 1993). 
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1.2.5 Transglutaminase reactive site 
Transglutaminases (TGs) are abundantly produced by numerous cell types 
including macrophages, keratinocytes and endothelial cells and a2M is the major TG 
substrate in human serum. (Van Leuven, 1984). The site of transglutamines reactivity is 
located approximately 20 amino acids upstream from the primary proteinase cleavage site 
in the bait region (Sottrup-Jensen, 1989). TGs catalyse the incorporation of primary 
amine and peptide into the TG reactive sites of a2M. (Borth, 1992). TG reactive site is 
also involved in the clustering of membrane bound aaM-proteinase complex and its 
endocytosis in a variety of cells (Imber and Pizzo, 1981; Mortensen et al, 1981). 
1.2.6 Carbohydrate chain 
Alpha-2-m.acroglobulins from all the investigated sources are glycosylated to 
varying extents. Dunn and Spiro (1967) reported that carbohydrates make up 9.43% of 
the total dry weight of human a2M. Pronase digest showed that human aiM contained 
31 carbohydrate chains per molecule with an average of 3 residues of maimose, 2 of 
galactose, 4.7 of N-acetylglucosamine, 1.5 of sialic acid and 0.4 of fucose. The 
carbohydrate unit is found attached to the polypeptide by glycosylamine linkage to the 
aspairagyl residue (Dunn and Spiro, 1967). Two points of attachment of these 
oligosaccharide have been identified, one is the thiol ester bond loop region and other is 
the 20 KDa receptor binding domain (Enghild et al, 1989). 
Rat aiM and a2M have almost similar carbohydrate content and are in close 
agreement with the results obtained from a number of other species (Gauthier and 
Mouray, 1976). Jamieson et a. (1972) however, obtained a higher hexose and sialic acid 
content in rat a2M as compared with other a2Ms. a2M from bovine and hamster contains 
nearly 10% by weight of asparagines linked carbohydrate as is the case of human PZP 
(Nagasawa et al, 1970; Southard and Talamantes, 1989). 
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Chicken aM and ovomacroglobulin terminates in galactose which mediates the 
clearance of aM-complexes by receptors present on various cell types whereas 4-0 
acetylated sialic acid is uniquely present on equine a2M (Prichitt and Paulson, 1989). 
ITie oligosaccharide structures of human, equine and guinea pig a2M has provided the 
complete structural information on the N-linked sugar chains of this plasma glycoprotein 
(Hanaoka er a/., 1989). 
The component sugar analysis of limulus a2M showed the existence of a complex 
type of oligosaccharide side chain similar to those of mammalian a2M. However, unlike 
mammalian a2M, no sialic acid was detected in limulus a2M and it contained 3 mol/ mol 
N-acetylglucosamine, suggesting the presence of 0-linked sugar chains which have not 
been found in mammalian a2M (Armstrong et al., 1991). 
1.3 Conformational changes 
When tetrameric aMs are incubated with proteinases or small molecular weight 
£imines their conformation undergoes remarkable alteration. These were originally 
characterized as change from the electrophoretically "slow" -S from to "fast" -F form. 
A variety of other physical methods have been used subsequently to follow the proteinase 
cind amine induced conformational changes like hydrodynamic techniques (Gonias et al, 
1982; Bjork and Fish, 1982) and small x-ray scattering (Branegaard et al, 1982; 
Osterberg and Malmester, 1984). Evidence from electron microscopy also revealed the 
remarkable reorganization of tetrameric aMs (Sottrup-Jensen, 1989). 
Proteinase and amine induced conformational changes in dimeric and monomeric 
aMs are less pronounced, but have been revealed by immunochemical procedures 
(Delain et al, 1988; Carlesson-Bostedt et al, 1988), UV-difference spectroscopy, 
circular dichroism and fluorescence (Sottrup-Jensen, 1987). 
A complex interplay between bait region cleavage and cleavage of the thiol ester 
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appears to contribute the conformational state of aMs. One consequence of the proteinase 
and amine induced conformational changes is the exposure of receptor recognition site on 
the molecule which allows rapid clearance of "fast" form from the circulation by a 
variety of cells (Van Leuven et al, 1979). Although receptor recognition site is exposed 
both in proteinases and amine induced form of most aMs, but the resulting conformation 
alteration differs subtly (Delain et ah, 1988) and mechanisms involved may vary for aMs 
from various species. Interaction of equine a2M with proteinases and methylamine 
resulted in clearly more than one conformational change as studied by circular dichroism 
and electrophoresis (Lah et al, 1987; Motoshima et al, 1988). Table 1.2 summarizes the 
receptor recognition site exposure after amine treatment in many species. 
In rat and rabbit a2M the amine induced thiol ester cleavage results in receptor 
recognition site exposure, but the characteristic large conformational change is only 
elicited subsequent to the bait region cleavage by proteinases (Longberg-Holm et al, 
1987; Tamamizu et al, 1989). Bovine and equine a2Ms do not display any difference in 
electrophoretic mobility between native and methylamine treated forms even though only 
the latter is receptor recognized (Bjork et al, 1985; Bjork and Jomvall, 1986 Motoshima 
et al, 1988). Spectroscopic studies also show that bovine a2M is altered only minimally 
by methylamine exposure consistent with no major change in secondary and tertiary 
structure of the protein (Bjork et al, 1989). In PZP and rat ails also the large 
conformation change and ftiU exposure of the receptor recognition site is only achieved in 
the methylamine induced form by subsequent bait region cleavage by proteinases (Table 
1.2) (Carlsson-Bostedt et al, 1998; Gliemann and Sottrup-Jensen, 1987). 
Longberg-Holm et al (1987) have observed by electron microscopy the 
conversion of globular ring shaped native forms of human and rat aiM to rectangular box 
like structures on proteinase treatment. Electron micrographs of rat aiM and a2M 
revealed compact and irregular shapes on proteinase interaction 
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The migration behaviour in polyacrylamide gel electrophoresis of the dimeric aM 
from plaice remains unaltered after treatment with proteinase (Starkey and Barrett, 1982). 
Unlike other dimeric aMs, limulus aM exhibit characteristic "slow" to "fast" 
transformation in electrophoresis (Quigley et ai, 1991). The monomeric rat Uih showed 
no alteration in electrophoretic mobility on reaction with methyiamine (Longberg Hobn 
etal., 1989). 
The trigger for the conformational change appears to be the cleavage at different 
positions within a large span of unique bait region sequence among the various aMs 
(Sottrup Jensen, 1989). Presumably, a profound reorientation of several domains occurs 
as a result of activation consistent with the findings that bait region cleavage of human 
a2M extensively erosslinked by cis-dichloro diammine platinum (II) does not result in 
thiol ester activation unless the crosslinks are subsequently removed (Roche et al., 1989). 
Much however seems to remain in the understanding of the conformational changes 
associated with thiol ester cleavage. 
1.4 Shapes and models of aMs 
Numerous studies on the shapes of native and transformed a2Ms are available. 
Native aMs frequently appear as irregular objects suggesting a slender structure 
(Longberg-Holm et al., 1987 Ruben et ai, 1988), or shaped like doughnuts (Tapon-
Bretaudiere et al.. 1985; Ikai et al.. 1987), padlocks (Delain et ai, 1988; Tapon-
Bretaudiere ^/fl/., 1985; Bergsma^/a/., 1985; Bretaudiere etai. 1988; Ikai e/a/., 1987) 
or like assemblies of four or five globules (Delain et ai. 1988; Bergsma et ai, 1985; Ikai 
et ai, 1987). It has recently been shown that all these shapes correspond to one single 
structure (Larquet et ai, 1994). In a three dimensional reconstruction of native human 
a2M the dimensions of the molecule were estimated to be 100 and 140 °A. In contrast 
electron micrographs of "fast" form obtained from human and other tetrameric azM 
reveal a well defined monogram like objects resembling the Cyrillic letter referred to as 
the )-( View (Bloth et ai. 1968). Its dimensions as estimated from projections of 
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different orientations and from three-dimensional reconstructions are 180-200 °A, 120-
140 °A and 80-90 "A (Tapon-Bretaudiere et al, 1985; Bretaudiere et al, 1988; Delain et 
al, 1992). Receptor recognition sites dxt located at the tip of the arms of the)-((Delain et 
al, 1988; Hussaini et al, 1990). Molecules probably representing intermediates in the 
transition from native to transformed a2Ms have also been observed (Delain et al, 1992; 
Gonias and Figler, 1989; Marshall et al, 1992). 
The proteinase(s) in the a2M-proteinase complex appear to partially fill a large 
elongated cavity (Delain et al, 1988; Boisset et al, 1989; Boisset et al, 1992; Schrocter 
et al, 1992) which seems to be empty in a2M-methylamine (Boisset et al, 1989; Boisset 
et al, 1992a;b; Schroeter e/ al, 1992). The flexible bait regions are relatively close to 
the thiol esters (Gettins et al, 1988; Gettins et al, 1990). The latter are probably located 
in the centre of the molecule at the inner surface of the cavity (Boisset et al, 1992 a & b: 
Boisset et al, 1994). Hydrodynamic data indicate an elongated shape of active dimers 
obtained by urea treatment (Liu et al, 1987; Roche et al, 1988a;b) whereas dimers 
formed by Zv?^ or Cd^ "^  appear as curved structures or rounded rods in which three 
globules can be seen (Delain et al, 1988; Thomas et al, 1988). In an electron 
microscopic study of chymotrypsin treated rat aJs, the molecule appears squarish with 
good contacts between the front and back parts and a well-defined internal cavity (Ikai et 
al, 1990). 
Several models differing in symmetry and localiza.ion of disulphide - bridged 
dimers have appeared (Liu et al, 1987; Bretaudiere et al, 1988; Delain et al, 1988; 
Feldmane/a/., 1985; Andersen eM/., 1995). 
The model shovm in Fig. 1.5 by Delain et al (1988) proposes that in native 
tetrameric human a2M two rod like disulphide-bridged dimers are assembled to form a 
cross-like structure. This model accounts for the generally elongated shape of the dimers 
and monomers and emphasizes that in native state the bait region segments are highly 
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Figure 1,5 Model 0/ liiiman a:M proposed by Delain et al. (1988) showing narive 
(A)and proteinase (raiisformed (B) a-M. 
B 
accessible to proteinases. The activated thiol esters face the lumen of the cavities 
positioned in close proximity to the surface of the trapped proteinases. 
1.5 Role of metal ions 
a2M functions as the major metal binding protein of human plasma. A number of 
metal ions have been shown to bind to a2M including cadmium (Watkins et al, 1982; 
Scott and Bradvvell, 1983), calcium and magnesium (Dumitrescu et al., 1977), nickel 
O^omoto et al., 1982) and zinc (Parisi and Vallee, 1970; Prasad and Oberleas, 1990). 
According to Adham et al. (1977), there are two classes of binding sites for zinc on aaM, 
the high affinity sites which bind 12g-atom of Zn^ "^  /mole of a2M protomer and the low 
affinity sites that bind upto 60 g-atom of Zn^ *. The reported dissociation constant (Kd) 
3.27 X 10" M by Adham et al. (1977) agrees with the subsequent findings of Pratt and 
Pizzo (1984) which proposes a Kd value of 8X10''M. . Likewise, neither saturation on all 
the high affinity sites with Zn * nor removal of all the zinc from a2M had any effect on 
the trypsin binding activity. However, saturation of the low affinity sites led to a 
remarkable decrease in trypsin binding activity which was ascribed to irreversible 
aggregation of a2M (Pratt and Pizzo, 1984). 
The distribution of zinc between a2M and other serum zinc binding proteins has 
been studied to assess the role of the inhibitor in zinc metabolism in health and disease 
(Falchuk,1977; Song and Adham, 1979). Gettins and Cunningham (1986) reported that 
the relative affinity of zinc for native ana methylamine modified form of a2M is 
different. Whereas, the affinity for Cd^ ^ of the methylamine modified and native forms 
were comparable, far fewer bindings sites were available in the former (Carson, 1984). 
They reported that a2M bound 30-40% of the total serum zinc. Pratt and Pizzo (1984) 
reported that at physiological human serum zinc concentration (10-15 ^M), a2M appears 
to bind 20 mole zinc / mole. Zinc bound to high affinity sites on a2M may be delivered 
to various tissues when the a2M-proteinase complexes are endocytosed (Maxfield et al., 
1978). 
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The structural and functional implications of zinc binding to a2M at high 
concentration of zinc, while not physiologically relevant, are useful as probes of protein-
metal interactions, particularly in relation to subunit association. The absence of 
profound effects on a2M structure or function at physiological zinc concentrations 
indicates that a^ M may play a role in zinc transport in vivo (Pratt and Pizzo, 1984). 
Couture-Tosi et al. (1986) observed that at low temperatures the dimers formed 
in^ "^  reassociate in long line 
arrangement and a helical periodicity. 
from Z ar polymers which display a regular chain like 
Carson (1984) carried out the interaction of Cd^ * with a2M and proposed a model 
that a2M binds CS^ with relatively high affinity and with a stoichiometry consistent with 
a single binding site per protein subunit. Occupancy of all measured sites by Cd 
parallels a small increase in the apparent ability of a2M to protect trypsin from 
inactivation by soyabean trypsin inhibitor. Later Pochon et al. (1987) reported the 
dissociation of a2M into dimeric units by Cd^ "^ . This dissociation is consistent with the 
presence of the binding sites for divalent cations at the contact surface of two a2M 
dimeric units. A detailed characterization of these binding sites, was not possible due to 
the aggregation of a2M above IxlO'^ M Cd^ "^  (Gettins and Cunninghams, 1986). 
1.6 Biological functions 
Surprisingly, while the a2Ms have been implicated in large variety of biological 
functions, their exact physiological roles continues to remain elusive. In view of their 
broad specificity in inhibiting proteinases they may have a general role in restricting or 
controlling proteolysis. Indeed in evolutionary terms they have been regarded as a part of 
a primitive defence mechanism against harmful intrinsic/extrinsic proteolytic enzymes 
(Quigley and Armstrong, 1983a). Besides controlling proteinases in concert with other 
inhibitors, they may function as backup inhibitors under conditions where primary 
inhibitors eventually become depleted, e.g. in clotting and fibrinolysis (Heumann and 
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Vischer, 1988; Petersen et ai, 1989). a2M may further bind proteinases dissociated from 
reversible proteinase - inhibitor complexes (Heumann and Vischer, 1988). 
Target proteinases for a2M may be found among those associated with ovulation 
(Gaddy-Kurten and Richards, 1991), matrix remodelling (Enghild et al, 1989), snake 
bites (Baramova et al, 1990), microbial infections (Miyoshi and Shinoda, 1991), viral 
iiiifections (Prichett and Paulson, 1989) and larval infection (Bowles and Feehan, 1990). 
Iliough a2M is not an acute phase reactant in humans and even partial deficiency is rare, 
the induction of synthesis of PZP during pregnancy in humans and aiM in the rat during 
inflammatory state suggests that these aMs may augment the existing potential for 
IMTOteinase clearance under such conditions (Chaudhari, 1993; Webb et al, 1995). In rat, 
(X2M probably has a predominant role, compared with human a2M as a TGF-P, carrier in 
Ihe plasma during the acute phase response. Rabbit a2M, an acute phase reactant has 
teen found to offer protection against corneal ulceration. (Berman et al, 1975). 
The occurrence of a2M complexes in plasma with severe illness viz acute 
pancreatitis (Donnelly et a/., 1983; Larson & Ohlsson,1984), leukaemia and metastatic 
melanoma (Hubbard, 1983) has earlier been reported from different laboratories. Bohn et 
d. (1980) reported that high doses of a2M are required to inhibit proteinase which plays 
a positive role in the transformation hence the clinical significance of a2M cannot be 
ruled out. 
The cleavage of thiol ester as a means of activating a2Ms probably reflects the 
concept that this form of a2M acquires new function, reminiscent of a binding, 
transporting and targeting protein that can modulate biological response. a2M has been 
identilied as a major plasma binder and carrier for several important cytokines. These 
includes transforming growth factor p-1 and p-2 (TGPP-l and P-2) (Daniel pour and 
Sporn, 1990; Huang et al, 1988; LaMarre et al, 1998), platelet derived growth factor 
(PDGF) (Bonner et al, 1990; Bonner et al, 1989), basic fibroblast growth factor (Dennis 
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et al, 1989), interleukin - 6 (IL-6) (Matsuda et ai, 1989). The conformation of a2M also 
appears to influence the affinity for cytokines. Human a2M in native state binds PDGF 
(Bonner ef al. 1990; Bonner et al 1989). TGF-P2 (Daniel Pour and Sporm 1990; 
LaMarre et al, 1990), TGF Pi(Huang et al, 1988) and IL-6 (Matsuda et al, 1989). 
Some cytokines that weakly or not at all bind to native a2M demonstrate preferential 
binding to "fast" form of a2M (LaMarre et al, 1991). TGBPi and TGFp2 bind 
preferentially to methylamine treated a2M (Huang et al, 1988). Similarly, tumour 
necrosis factor (TNF-a) and IL-2 binds to "fast" form of a2M (La Marre et al, 1991; 
Borth and Luger, 1989). The nature of binding of cytokine varies with different 
cytokines. It could be non covalent as in case of TNFa and TNF-P (Huang et al, 1988) 
or it could be thiol ester dependent mechanism as of IL-2 (Legres et al, 1995). The 
binding between cytokine and a2M could be the result of thiol disulphide interchange as 
v/ith IL-2 (Legres et al, 1995) or could be other type viz TGF p/a2M complex which can 
be dissociated by heparin (McCaffery et al, 1989). By functioning as cytokine carrier, 
native a2M may lengthen plasma life of bound cytokine and the a2M-cytokine complexes 
may be dissociated by proteinases (Matsuda et al, 1998), low pH (Huang et al, 1988) or 
heparin (LaMarre et al, 1990) normally present near the cell surface. The a2M cytokine 
complex are cleared in vivo via the a2M receptor (LaMarre et al, 1991). 
The aMs have a unique ability to bind a wide variety of other molecules and ions 
such as soluble la antigens, histones, encephalitogenic protein, zmc, nickel, lithium 
carmine, liposomes and immune complexes (James, 1980). Human a2M is a major zinc 
binder and carrier protein (Parisi and Vallee, 1970). Zinc is not required for proteinase 
binding function of a2M, but may be essential for the binding of cytokines such as IL-P 
(Borth and Luger, 1989; Borth et al, 1990). 
Other specific roles for a2M have also been suggested. For instance a study has 
indicated the potential of a2M in reducing harmful free radical production (Donnelly et 
ai, 1991). a2M have implicated in modulating proteotylic cleavage of various peptide 
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hormones (Rinderknecht and Geokas, 1973). Other evidence suggest that a2M is 
important in modulating various immune responses as well as in inflammatory response 
(James, 1980). Hubbard et al. (1987) have shown that aiM acts as a immuno suppressive 
agent in its proteinase complex form. 
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Experimental 
2.0 MATERIALS 
Chemicals and reagents used in this study were obtained from the following 
sources as details below. Glass distilled water was used in all the experiments. 
B.D.H. Poole, England. 
Bromophenol blue. 
B.D.H. India. 
Copper sulphate, Ethanolamine, Ethylenediamine, tetraacetic acid, Hydrochloric acid. 
Trichloroacetic acid, Phenol. 
C.D.H. India. 
Sodium thiocyaiiate. 
Difco Laboratories, U.S.A. 
Freund's Complete Adjuvant, Freunds incomplete adjuvant. 
E. Merck., India. 
Ammonium sulphate, Dithiozone, Glycine, Methanol, Sodium hydroxide, Sodium 
F'otassium tartarate. 
E. Merck, Germany. 
Pronase E, Proteinase K. 
Genei Pvt. Ltd., Banglore. 
High molecular weight marker. 
Koch-light Lab. Ltd., England. 
N,N,N',N' - tetKimethylene diamine. 
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Merck-Scheveherdt., Germany. 
p-mercaptoethanol. 
Pharmacia Fime Chem., Sweden. 
Blue dextran, Sephadex G-200, Sephacryl S-300 HR, Sepharose-4B. 
Qualigens, India. 
Acetic acid, acetonitrile, Di-sodium hydrogen phosphate, glycerol isopropanol, Di-
hydrogen sodium phosphate, potassium iodide, potassium chloride, sulphuric acid, 
sodium chloride, sodium bicarbonate, sodium carbonate, zinc chloride, glucose, 
methylamine. 
Sisco Res. Lab., India. 
N,N'-methylene biscacrylamide, acrylamide, ammonium persulphate, bovine serum 
albumin, chymotrysin, casein, cyanogen, bromide, Folins ciocalteu's phenol reagent, 
glutathione, N,N'-Dithio (bis) nitrobenzoic acid, sucrose, sodium citarate, trypsin. 
Sigma Chemical Co., U.S.A. 
Agarose, apoferritin (Horse Spleen), DL-Benzoyl arginine p-nitroanilide, coomassie 
brilliant blue R-250, p-galactosidase, phenyl methyl sulphonyl fluride, sodium dodecyl 
sulphate, soyabean trypsin inhibitor, thyroglobuliun (Bovine), Tris (hydroxymethyl) 
amino methane, ovalbumin, Hemoglobin. 
Siarabai Chemicals, India. 
Dimethyl sulphoxide. 
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3.0 METHODS 
3.1 Purification of buffalo blood aIpha-2-macroglobuIin 
Fresh buffalo blood was collected from the abbatoir immediately after slaughter 
into bottles containing 1.32% (w/v) sodium citrate and ImM PMSF/SBTI. The plasma 
separated from the cells by centrifugation at 750 g was collected. 
3.1.1 Ammonium sulphate fractionation 
One hundred millilitre of buffalo plasma was 20% saturated with ammonium 
sulphate with gentle stirring at 4°C. After 4-6 h, the precipitate was removed by 
centriftigation alJ750 g for 15 min. and the supernatant collected was made 40% saturated 
with ammonium sulphate. The solution was allowed to stand at 4-6 C for 8 h, the 
precipitate recovered by centriftigation atl750 g for 20 min and dissolved in 20 ml of 
distilled water. The fraction was extensively dialysed against several changes of ice-cold 
buffer (0.1 M sodium phosphate buffer containing 0.1 M KCl, pH 8.0). 
3.1.2 Gel filtration chromatography 
A Sephadex G-200 column was prepared as recommended by Peterson and Sober 
(1962). The gel was allowed to swell in sufficient amount of distilled water for 6 h in a 
boiling water baith. The gel fines were removed by suspending the gel in two to four fold 
excess O.IM sodium phosphate buffer, pH 8.0 and allowing 90-95 % of the gel to settle 
down. The remaining gel in supernatant was rapidly removed by suction. A glass column 
mounted on a sturdy vertical support was filled to one third of its length with operating 
buffer in order to check leaks and flush air bubbles from the dead space. The deaerated 
gel slurry was then poured with a help of glass rod into the column with care to avoid 
generating air bubbles. The column was left standing overnight. Flow rate was increased 
gradually and after accomplishing a constant flow rate higher than that required for final 
elution the column was adjusted to the required flow rate. The packed column was 
thoroughly washed with two bed volumes of operating buffer (O.IM sodium phosphate 
buffer containing O.IM KCl, pH 8.0). In order to check uniform packing and to determine 
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the void volume of the column, 2% (w/v) solution of blue dextran in 0.1 M sodium 
phosphate buffer, pH 8.0 was passed through the column. The volume of blue dextran and 
protein solution applied was not more than 2-3% of the total bed volume. Three millilitre 
fractions were collected and assayed for protein and a2M activity. Homogenity of the 
preparation was analyzed by 5% PAGE. 
3.2 Colorimetric Analysis 
3.2.1 Determination of protein concentration 
Protein was estimated by the method of Lowry et al. (1951). Aliquots of protein 
solution were taken in a set of tubes and final volume was made upto 1 ml with 0.01 M 
sodium phosphate buffer, pH 8.0. Five ml of alkaline copper reagent (containing one part 
of 0.5%(w/v) copper sulphate in l%(w/v) sodium potassium tartarate and 50 parts of 
2%(w/v) sodium hydroxide) was added followed after 10 min of incubation at room 
temperature, with 0.5 ml of l.ON Folins-Ciocalteu's phenol reagent. The tubes were 
instantly vortexed. The colour developed was read at 660 nm after 30 min against a 
reagent blank. A standard curve was prepared using BSA as standard. Protein in the 
column fractions was monitored at 280 nm in Beckman DU-40. 
3.2.2 Assays of ttiM activity 
a2M activity was quantitated either by its ability to inhibit proteolytic cleavage of 
casein by trypsin (Kunitz,1947) or trypsin esterase activity described by Ganrot (1966). 
Inhibitory assay of aaM was performed as described by Kunitz (1947). Buffalo 
a2M was examined for its ability to prevent various proteinase(s) from digesting casein. 
For determination of inhibitory activity, a2M proteinase(s) complex was incubated with 
casein for 15 min in 0.1 M sodium phosphate buffer, pH 8.0 and reaction stopped by the 
addition of 20% TCA. Acid insoluble material was removed by centrifiigation at 1750 g 
for 15 min. The supernatant was analyzed for acid soluble peptides with Folin's phenol 
reagent as described by Lowry et al. (1951). 
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a2M activity was also measured by its ability to protect trypsin esterase activity 
(TPE-activity) from SBTI, as described by Ganrot (1966). Appropriate amounts of the 
inhibitor were diluted to I.O ml with 0.01 M sodium phosphate buffer, pH 8.0. To this 
was added 0.1 ml of 0.1% trypsin (prepared in 0.0025 N HCl). After incubation at 37°C 
for 10 min, 0.1 ml of 0.1% SBTI (prepared in 0.0025N HCl) was added and the sample 
incubated for further 10 min. Two miililitre of freshly prepared BAPNA solution 
(prepared by dissolving 43.5 mg BAPNA in 1.0 ml DMSO and then the solution was 
brought to 100 ml with phosphate buffer) was added to the reaction mixture and the final 
volume to made 3.0 ml with the buffer after which samples were incubated 
simultaneously. The reaction was stopped by addition of 0.5 ml of 30% acetic acid and 
the absorbance of the yellow coloured p-nitroanilide formed was determined at 410 nm. 
'^ fhe amount of substrate hydrolyzed by the enzyme was calculated using molar extinction 
coefficient of 8800M "'cm'' for p-nitroanilide at 410 nm. 
3.2.3 Carbohydrate estimation 
The procedure described by Dubois (1956) was followed. Two miililitre aliquots 
containing 10 to 70 |jg of carbohydrate was pipetted into a test tube and 0.05 ml of 80% 
phenol added. This was followed by the addition of 0.5 ml of concentrated sulphuric acid, 
the stream of acid being directed against the liquid surface rather than against the side of 
the test tube in order to obtain good mixing. The tubes were allowed to stand for 10 min. 
thoroughly mixed and again incubated for 20 min. at 30°C. The colour intensity was 
measured at 490 nm for the quantitation of hexose content. Glucose was used as the 
standard. 
3.2.4 Zinc estimation 
Zinc estimation in plasma and a2M was performed as described by Song et al. 
(1976). To 1.0 ml aliquot containing 0.03 to 5 i^g zinc, 0.1 ml of dithiozone solution 
(prepared by dissolving Img dithiozone in 1.0ml of IM Tris buffer, pHl 1) was added and 
after mixing the absorbance was read at 555 nm in Spectronic-21 spectrophotometer. 
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Two blanks were prepared, one containing distilled water and dithiozone, the other 
containing zinc but no dithiozone. The blank readings were subtracted from the 
absorbance of the samples being assayed and zinc content determined from the standard 
graph. Appropriate aliquots of a2M were also analyzed similarly for the zinc content. 
To 3 ml of plasma in a plastic tube 30 mg potassium iodide was added, and after 
mixing 0.15 ml of 100% TCA was added. The sample was then shaken, allowed to stand 
at room temperature for 10 min, and centrifuged at 3,600 g for 30 min.The pH of the 
supernatant was adjusted to approximately 13.5 by adding 0.1 ml, 10 M NaOH per 1.0 ml 
supernatant. The mixture was allowed to stand for 15min and centrifuged as above. The 
precipitate (CaOH)2, (MgOH)2, (CoOH)2, (MnOH)2 and (FeOH)2 was discarded and to 
0.8 ml of the supernatant, 0.1 ml of 6 N HCl and 0.1 ml of saturated Tris buffer were then 
added in this order, followed by 0.1 ml dithizone reagent in IM Tris buffer. The pH of 
this mixture prior to addition of saturated Tris buffer remained between 1 and 8.5. 
Absorbance was determined at 555 nm. 
3.2.5 Thiol group estimation 
The procedure described by Ellman (1959) was followed for the estimation the 
thiol groups of a2M. Trypsin and methylamine induced appearance of free thiol groups in 
the a2M was followed by titration with DTNB reagent. Appropriate aliquots of 0.5 ml, 
native, trypsin or methylamin'=; treated a2M were mixed with 0.1 ml of DTNB reagent 
(prepared by dissolving 80 mg in 0.2 ml of 0.05 M Tris-EDTA buffer, pH 8.0) in a total 
volume of 3.1 ml. The absorbance was read after 15 min at 412 nm in Beckman DU-40 
recording spectrophotometer. Free thiol concentration was calculated from the 
absorbance, using molar extinction coefficient of 13,600 M'' cm"' for the thionitrobenzoic 
acid group released. A standard plot was prepared using glutathione. 
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3.3 Preparation of modiHed a2M 
3 J . l Treatment with methylamine 
Appropriate amount of a2M was incubated with 0.5 M methylamine in O.IM 
sodium phosphate buffer, pH 8.0 at 22°C for 24 h. The protein was then extensively 
dialysed against O.IM sodium phosphate buffer, pH 8.0 (Imber and Pizzo, 1981). 
3.3.2 Treatment with trypsin 
Appropriate aliquots of a2M were incubated with 2-fold molar excess of trypsin 
at37°Cforl5 min after which the proteolysis was inhibited with a 100-fold molar excess 
of PMSF. Alternatively, a2M was also treated with three-fold molar excess of 
iimmobilized trypsin for 3 h at 37°C. The inhibitor was separated from the immobilized 
trypsin by centrifogation. 
3.4 Slab Gel Electrophoresis 
3.4.1 Polyacrylamide gel electrophoresis (PAGE) 
PAGE was performed by the Tris-glycine system of Laemmli (1970) using the 
apparatus manufactured by Biotech, India. Concentrated stock solution of 30% 
aciylamide containing 0.8% bisacrylamide and 1.5 M Tris pH 8.8 were mixed in 
appropriate proportions to the required final concentration. It was then poured into the 
mould formed by two glass plate (8.5x10 cm) separated by 1.5 mm thick spacers. Bubbles 
and leaks were avoided A comb providing a template for 7 samples wells were inserted 
into the stacking gel solution before polymerisation began. The polymerisation was 
complete in aboui 30 min. after which the comb was removed and wells overlaid with the 
running buffer. Routinely, a 5% acrylamide gel was used. Samples containing 10-20 |ig 
of protein were prepared to give a final concentration of 62.5 mM Tris-HCi pH 6.8, 
10%(v/v) glycerol and 0.001% bromophenol blue as a tracking dye. 
3.4.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was essentially performed by the method of Laemmli (1970). 
Concentrated stock solutions were mixed in the appropriate order to give a final 
concentration of 7.0%. Protein samples were prepared in solution containing of 62.5 mM 
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Tris-HCl pH 6.8, 10%(v/v) glycerol, 2%(w/v)SDS, 5%(v/v) p-mercaptoethanol and 
0.00!% (w/v) bromophenol blue. The samples were incubated at 37°C for 45min. 
Electrophoresis was performed at lOOV till the tracking dye reached the bottom of the 
gel. Running buffer used during electrophoresis contained 1% SDS in addition to 192 
mM glycine and 25 mM Tris-HCl pH 8.8. 
3.43 Coomassie Blue Staining 
After electrophoresis, the gels were stained with five gel volumes of 0.25% 
Coomassie brilliimt blue R-250 in 50% methanol and 10% acetic acid for at least 4 h. For 
destaining the gels were incubated with shaking in 5% methanol and 7.5% acetic acid at 
room temperature. 
3.5 Molecular weight determination 
The molecular weight of buffalo a2M was determined under native and denaturing 
conditions by gel filtration and SDS-PAGE respectively. 
The molecular weight of buffalo a2M and a2M half molecule formed by urea was 
computed from its elution volume on a Sephacryl S-300 HR column (2.5x 85 cm).The 
coiunm was calibrated by determining the elution volume of several globular proteins-
thyroglobulin (668 KDa), Appoferritin (440 KDa), p-galactosidase (116 KDa), 
He:t>oglobin (64 KDa) and Ovalbumin (45 KDa). The data was analysed according to the 
theoretical treatment of Andrews(1964).The linear plot between Ye/Wo and log M was 
used in calculating the molecular weight of buffalo a2M and its half molecule. 
Subunits molecular weight of a2M was calculated by the procedure of Weber and 
Osbom (1969) using SDS-PAGE. The mobilities of marker proteins determined under 
idoitical condition were plotted against the logarithm of molecular weight. The standard 
protein used were myosin (205 KDa), phosphorylase (97 KDa), bovine serum albumin 
(68 KDa), ovalbumin (43 KDa) and carbonic anhydrase (29 KDa). The analysis of data 
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indicated a Vmeai relationship between Log M and relative mobility (Rm) and the plot 
was used in calculating the subunit molecular weight of a2M. 
3.6 Determination of Stokes radius 
Size exclusion chromatography on Sephacryl S-300 HR (2.5 x 85 cm) column 
equilibrated with 0.1 M sodium phosphate buffer, pH 8.0 containing 0.1 M KCl, was used 
l:o determine the Stokes radius of a2M and a2M half molecules. The flow rate was 
maintained at 50 ml h'' and the absorbance of the eluent was monitored at 280 nm. The 
Stokes radius of a2M and its half molecule was determined by the method of Laurent and 
Killander (1964) using gel filtration data. The standard proteins used were thyroglobulin 
(86°A), Apofenitin (59°A), catalase (52°A), aldolase (46°A) and bovine serum albumin 
(35.5''A). The value of Kav of each marker protein was calculated from the formula 
Kav = Ve - Vo / Vt- Vo 
By substituting the values of (Ve elution volume) 
Vo (void volume) 
Vt (total volume of column) 
A graph of the square root of the negative logarithm of Kav versus stokes radius 
gave a linear plot which was used in calculating stokes radius of buffalo a2M and aaM 
half molecule. 
3.7 Amino acid analysis 
Protein (500 ^g) was hydrolysed with 6 N HCl at 1 lO^ 'C in sealed ampoules. The 
digested sample were redried in a mixture of ethanol, water and TEA in a ratio of 2:2:1 in 
vacuo. This wiis followed by derivitization of amino acids. A mixture of ethanol, TEA, 
water and PITC in a ratio of 7:1:1:1 was added to a2M sample at 22°C and left for 20 
min. Again the sample was dried in vacuo and resuspended in sample diluant which was 
filtered by passing through sample clearance filter (0.25 fim). A 40 i^l of sample was 
then finally injected in automatic amino acid analyser. 
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Peak of respective amino acid spectra was worked out matching with standard 
amino acid peaks. Concentration of each amino acid was calculated by measuring the area 
of the respective peak. Number of amino acid in the protein were calculated by dividing 
the concentrations of each amino acid by total concentration of amino acid in the protein 
and multiplying by total number of amino acid residues in the protein. On hydrolysis, 
asparganinfc and glutamine are converted to aspartic and glutamic acid and hence were 
calculated together with those amino acids. Tryptophans were determined 
spectrophotometrically by the method proposed by Beaven and Holiday (1952). 
Tryptophan content was calculated from molar tyrosine/tryptophan ratios measured 
spectrophotometically in 0.1 M NaoH, at the wavelengths (280,294.4 nm). 
3.8 Immobilizaton of trypsin 
Trypsin was immobilized on Sepharose-4B. Activation of Sepharose-4B was 
performed as described by Porath et a/. (1967). For this purpose lOg of Sepharose-4B was 
washed thoroughly with distilled water in a sintered glass funnel. The gc! was sucked dry 
and suspended in 10.0 ml of distilled water and 10.0 ml of 2 M Na2C03 was added, mixed 
thoroughly by placing on a magnetic stirrer. Two millilitre of acelonilrile containing 2.0 
grams cyanogen bromide was added to the beaker containing Sepharose and the contents 
were mixed thoroughly at 4"C for 10 min. The whole mass was immediately transferred 
to a glass sintered funnel and washed successively with 0.1 M bicarbonate buffer, pH 8.5, 
distilled water and once again with buffer. After throughly washing the activated 
Sepharose for 24h in cold. The Sepharose 4B bound protein was separated by 
centrifugation and protein in supernatant was quantitated in order to calculate the amount 
of protein immobilized. The protein matrix was thoroughly washed with 0.1 M sodium 
bicarbonate buffer, pH 8.5 containing IM sodium chloride and then 0.1 M sodium 
bicarbonate buffer, pH 8.5. The washed suspension was treated with 0.1ml of 98% 
ethanolamine for 2h at 4°C. The matrix was then v/ashed with 0.1 M sodium chloride, 
distilled water and finally with the buffer. 
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3.9 Immunological procedures 
3.9.1 Immunization of rabbits 
Antibodies against buffalo a2M were raised in liealthy male albino rabbits. 250 jig 
of electrophoretically pure a2M in 0.5 ml of normal saline emulsified with equal volume 
of Freund's complete adjuvant was injected subcutaneously. Two weeks later 125 ng of 
ttaM was injected along with Freund's incomplete adjuvant. A similar second booster 
dose was given in the third week and the animal was bled after an additional one week. 
The blood collected was allowed to coagulate at 22''C for 3 h. The antisera was 
decomplemented at ST^ C for 30 min and stored at -20''C in small aliquots. 
3.9.2 Immunodiffusion. 
Immunodiffusion was performed essentially by the method of Ouchterlony 
(1962). One percent molten agarose in normal saline containing 0.2% sodium azide was 
poured in on glass plate and allowed to solidify at room temperature. Required number of 
wells were cut and the slides were stored at 4°C. Five to ten microlitres of suitably diluted 
antisera and required amount of antigen prepared in normal saline were added in different 
wells. The reaction was allowed to proceed for 12-24 h in a moist chamber at room 
temperature. The petriplates were immersed in normal saline to remove non-specific 
precipitin line. 
3.10 Dissociation of a2M and methylamine treated a2M with NaSCN 
Dissociation of a2M by NaSCN was followed by the method of Shanbhag et al. 
(1996). This was performed by incubating native and methylamine treated a2M with 
various concentration of NaSCN in 0.1 M sodium phosphate for 60 min. were then 
diluted to achieve 0.2 M NaSCN concentration, prior to electrophoresis. The extent of 
dissociation was determined by electrophoresis using non-denaturing conditions on 5% 
polyacrylamide gel. Native a2M incubated with 1%SDS for 90 min at room temperature, 
was used as marker for the position of the tetrameric and dimeric forms of a2M 
respectively. The gel were stained with coomassie brilliant blue R-250. 
44 
3.11 Spectroscopy 
3.11.1 Fluorescence spectroscopy 
Native and zinc treated a2M subjected to methylamine and trypsin treatment were 
analyzed by measuring intrinsic fluorescence at 20±0.2°C in Hitachi F 2000 
spectrofluorimeter (Tokyo, Japan). The protein was excited (Xex) at 280 nm and 295 nm. 
Corrected emission spectra were recorded with excitation and emission bandwidths of 10 
nm. Appropriate controls containing the substances used for the treatment were run and 
corrections made wherever necessary. 
The time course of the change in intrinsic fluorescence at 20±0.2''C was followed 
by measuring the fluorescence in Hitachi F-2000 spectrofluorimeter. To study 
tiyptophanyl fluorescence a2M was excited at 295 nm whereas to analyze the cumlative 
effect of tyrosine, tryptophan and phenylalanine, the protein was excited at 280 nm. 
Dissociation of native and methylamine-treated ajM by 1.6 M NaSCN was studied. 
Solutions of a2M and NaSCN in 0.1 M sodium phosphate buffer, pH 8.0, were mixed in a 
fluorescence cuvette to obtain a final concentration of 0.05 mg/ ml of a2M and 1.6M 
NaSCN. The temperature was maintained at 22°C by thermostating the cuvette housing 
during the measurement. The time of mixing was defined as t=0. The fluorescence spectra 
at known times were recorded and the change in relative fluorescence (AF) was calculated 
at 340 nm. 
3.11.2 Circular dichroism spectroscopy 
Circular dichroism spectra of native a2M and that after various treatments were 
measured in a Jasco J 720 spectropolarimater equipped with a temperature controlled 
sample cell holder. Spectra were collected with a scan speed of 20 nm/min. and with a 
response time of Is. Each spectrum was the a\'erage of four scans. Measurements in the 
far UV (200-250 nm) were taken using a2M concentrations of about 500 nM (i.e. about 
0.35 g/litre), with a 1 mm pathlength cell whereas cells with 10 nim pathlength and a2M 
concentrations of about 1.5 ^M (1.2 g/litre) were used in the near UV (250-300 nm) 
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region. For each sample, a solution of methylamine or trypsin of the same concentration 
was used as a blank. 
The results were expressed as mean residue ellipticity (MRE) in deg.cm .^d mol"' 
which is defined as 
MRE = eobs(mdeg)/(10xnxlxcp) (1) 
where Gobs is the CD in millidegree, n is the number of amino acid residues, 1 is 
the pathlength of the cell and Cp is the mole fraction. The a-helical content of a2M was 
calculated from the MRE value at 222 mn using the following equation as described by 
Chen era/. (1972) 
% helix - [(MRE222 - 2340) / 30300] X 100 (2) 
The results in the near-UV CD were expressed as molar ellipticiites. 
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Results 
4.0 PURIFICATION AND CHARACTERISATION OF BUFFALO ALPHA-2-
MACROGLOBULIN 
4.1 PURIFICATION - The purification procedure used in the present study is a 
combination of ammonium sulphate fractionation and size exclusion chromatography. 
Buffalo plasma proteins precipitated between 20-40% ammonium sulphate saturation 
were dissolved in 0.1 M sodium phosphate buffer, pH 8.0 containing 0.1 M KCl, and 
dialysed against the same buffer. This resulted in 2-fold purification and 80% yield 
(Table 4.1). Figure 4.1 shows the elution profile of the ammonium sulphate fractionated 
protein on a Sephacryl S-300 HR column. a2M was eluted in the first protein peak which 
was followed by a second peak lacking a2M activity. The fractions of first peak migrated 
£is a single band in polyacrylamide gel electrophoresis under non-denaturing conditions 
suggesting homogenity (Fig. 4.2). The two step scheme resulted in 35-fold enrichment in 
s;pecific activity and a yield of 61% . Purification of buffalo a2M is summarized in 
(Table 4.1). 
Purification of buffalo a2M preparation was also followed by PAGE performed 
both in presence and absence of SDS. Unfractionated plasma and 20-40% ammonium 
sulphate fractions showed a prominent band of a2M in addition to several other proteins. 
After gel filtration the first peak fractions migrated as single band in PAGE ( Fig. 4.3 ). 
A single band was also obtained when the purified buffalo a2M was subjected to SDS-
PAGE in presence of the thiol reductant P -mercapthoethanol (Fig. 4.4). 
4.2 SOME PROPERTIES OF PURIFIED BUFFALO a2M 
4.2.1 Molecular weight - The molecular weight of buffalo a2M and a2M half molecule 
was determined both under native and denaturing conditions. The subunit molecular 
weight of a2M was calculated fi-om its mobility in SDS-PAGE by the procedure of 
Weber and Osbom (1969). The mobilities of marker proteins were plotted against the 
logarithm of their molecular weights (Fig. 4.5). Least square analysis of the data 
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TABLE 4.1 
Purification of buffalo plasma a2M 
Plasma 
Ammonium 
sulphate 
fractionation 
Gel filtration 
Volume 
(ml) 
100 
25 
125 
Total 
protein 
(mg) 
6900 
2940 
120 
Total 
activity 
(units) 
638 
510 
390 
Specific activity 
(units/mg 
protein) 
0.091 
0.173 
3.16 
Purification 
(fold) 
-
1 
2.0 
35 
Recovery 
(%) 
100 
80.0 
61.1 
Protein concentration was determined by the method of Lowry et al. (1951) 
One unit of inhibitory activity is that amount of entrapped trypsin which catalyses the 
formation of 1 micromole of p-nitroanilide per 30 min. 
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Figure 4.1 Size exclusion chromatography 
The ammonium sulphate precipitate obtained from 100 ml of buffalo 
plasma was dissolved and dialysed against several changes of O.IM 
sodium phosphate buffer, pH 8.0 containing O.IM KCl at 4°C. The 
fraction was applied on Sephacryl S-300 HR column (2.5 x 82cm) and 
eluted with the buffer at the rate of 30 ml/h. Fractions of 3.0 ml were 
collected and assayed for a2M and protein concentration. 
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Figure 4.2 Gel electrophoresis of the purified a2M 
Electrophoresis was performed on 5.0% acrylamide gel as described under 
materials and methods. Lane a, b, c, d, e, f, g contained fractions 
5,7,9,10,12,14 &16 respectively from the first peak of the Sephacryl S-300 
HR column. Fifteen jxg of protein was applied in each lane. 
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Figure 4.3 Gel electrophoresis of buffalo azM during various stages of 
purification 
Electrophoresis was performed on 5.0% non-denaturing gel as described 
under methods. Lane a, b and c contained buffalo plasma, 20-40% 
ammonium sulphate fraction and the fraction obtained after gel filtration 
respectively. Fifty jig protein was applied in lanes a and b while lane c 
contained 15|ag. 
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Figure 4.4 SDS-Polyacrylami(]e !;el electrophoresis at various stages of 
purifiiijition of buffalo :!.2M. 
Eillectrcfihoresis was perlbrm(;d on 7.5% acrylamide gel as described under 
method:;. Lanes a, b and c contains buffalo plasma, 20-40% ammonium 
sulpha:^ fraction and the fraction obtained after gel filtration, respectively. 
50(ig protein was applied in lane a &. b and 15)ig of protein was applied 
in lane c. 
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Figure 4.5 Molecular mass determination of buffalo a2M by SDS-PAGE 
Electr()j)horesis wa,s performed on 7.5% acrylamide gel as described in the 
methodi- section. The gel lane a contained the molecular mass standards: 
1- my:)iin (205 KDa), 2- phosphorylase b (97.4 KDa), 3- bovine serum 
albumin (66 KDa), 4- Ovalbumin (45 KDa), 5- carbonic anhydrase (29.1 
KDa). Lane b contained 15fig of P-mercaptoethanol treated buffalo a2M 
(Panel A). The relative mobility of the marker proteins were plotted 
against their molecular weight using least square analysis. The position of 
a2M sul)unit is indicated by arrow. 
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indicated a linear relationship between log M and relative mobility (Rm) and the position 
of migration of a2M subunit corresponded to 165 KDa (Fig. 4.5). 
The molecular weight of the native a2M and aaM half molecule formed by urea 
were determined using gel filtration chromatography on Sephacryl S-300 HR. The 
marker proteins (Thyroglobulin, Apoferritin, P-galactosidase, haemoglobin, and 
ovalbumin), the purified a2M and a2M half molecule were chromatographed on a 
column of Sephacryl S-300 HR (2.5 X 82 cm) equilibrated with O.IM sodium phosphate 
buffer, pH 8.0 <md their elution volume determined. Analysis of data indicated a linear 
relationship between log M and VeA'o, where Ve is the elution volume of a protein and 
Vo is the void volume of the column determined using blue dextran. 
The V/Vo of native buffalo a2M and that determined in the presence of 4 M urea 
corresponded to apparent molecular weight of 660 KDa and 332 KDa respectively (Fig. 
4.6). 
4.2.2 Stokes Radius - The Stokes radius of buffalo a2M and urea induced half 
molecules were determined fi-om their elution volumes from a calibrated Sephacryl S-300 
HR column (Fig. 4.7). The column was calibrated by determining the elution volume of 
several globulai" proteins with known Stokes radii. The data was analysed according to 
the theoretical treatment of Laurent and Killander (1964). The linear plot between stokes 
radii and [-log Kav]'^  of the marker proteins was used for calculating the Stokes radii 
which were 85''A and 67.2V respectively for the native and half molecules. 
4.2.3 Effect of Trypsin - Purified buffalo a2M treated with two fold molar excess 
trypsin for 10 min at 37°C showed the characteristic "slow" to "fast" transformation on 
electrophoresis in non-denaturing polyacrylamide gels (Fig. 4.8). A similar increase in 
the electrophoretic mobility was also observed when a2M was exposed to immobilized 
trypsin for 2 h at 37°C (Fig. 4.9). 
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Figure 4.6 Moli.'oular weight estiimatio i of native buffalo a2M and urea induced 
half molecules using Sepharose-4B gel filtration chromatography. 
Puriri;d buffalo 02M \.-as iipplied to a column (2.5 x 82cm) of Sepharose-
4B and eluted v/ith (i.lM sodium phosphate buffer (pH 8.0 containing 
0.1 N'[ <iC\) at a flow lute of JOmlA:.. The molecular weight markers used 
wen; thyroglobulin (T'H, 6()0, KDa), apoferritin (AF, 440 KDa), P-
gala;;t()sidase (GL, 116 KDa), haemoglobin (Hb, 64 KDa) and ovalbumin 
(Ov;j, 45 KDa). The positi(>n of elution of native and urea dissociated 
mol<;c JICS is indicated with atrows A and B respectively. 
4c Vi 
( Ace. No ' J 
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Figure 4.7 Dete»niination of Stokes radius of buffalo azM and azM half molecule 
by Liiurenf and Killaiider plot. 
The purified buffalo ajM, (1.2M half molecule obtained by urea treatment 
and i:i;.rker proteins were subjected to gel filtration on Sepharose-4B as 
descr:b:ui earlier. The ICav A'abes were computed from the elution volume 
of niaiker proteins. Stoke;; radii for the marker proteins were 1, 
thyroj^ ; jhnhn (86 'A) 2, appoferritm (59 A) 3, bovine serum albumin 
(35.5"/*.) 4, ovalbumin (27.3^\) 5. Soyabean trypsin inhibitor (22.4'^ A). 
The Stokes radii of a2i^i, 0.2W. half molecule formed by urea and NaSCN 
are iruiicaKed by ari'ows A ar;d B respectively. 
J6 
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Figure 4.8 Effect of Trypsinization on buffalo a2M 
Electrophoresis was performed on 5% non-denaturing acrylamide gel as 
described under methods. Buffalo a2M was treated with 3-fold molar 
excesj; of trypsin at 37'^ C for 10 min and reaction stopped by the addition 
of 0.001 M PMSF. Lane a, native (X2M (20 )ig). Lane b, trypsinized a2M 
(20 pg,). 
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Figure 4,9 Gel eleCiTophoresis of buffalo a2M after treatment with soluble and 
immobilixed trypsin . 
The ele:-i:fophoresis was performed on 5% non-denaturing acrylamide gel 
as desc'ibed in methods section. Buffalo a2M was treated with 2-fold 
molar i.> ;e:-.s of soluble trypsin at 37'C for 10 min and reaction was 
termina;(:d by addition of ImM PMSF and a2M was treated with 3-fold 
molar e;<(;ess of Sepharose-linktd trypsin. Lane a, native a2M. Lane b, 
(X2M trocted with soluble trypsin. Lane c, a2M treated with immobilized 
trypsin. iO p,g of protein v^as applied on each lane. 
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4.2.4 Effect of Methylamine - Sensitivity of the thiol ester towards small nucleophiles 
like methylamine is characteristic of aMs from various sources (Gonias et al.,1982). 
Buffalo a2M incubated with 0.5 M methylamine for upto 24h at 22°C still retained 42% 
of its original tr/psin inhibitory activity as shown in Table 4.2. Incubation of a2M with 
methylamine lead only to small increase in electrophoretic mobility that was intermediate 
between native and trypsin treated a2M. Trypsinization of the methylamine treated, a2M 
however, transformed the intermediate form of the inhibitor to the "fast" form. (Fig. 
4.10). 
4.2.5 Inhibition of Proteinases - The antiproteinase role of a2Ms from variety of 
sources has been identified by inhibition of a broad spectrum proteinases and their 
protection from inhibition by large molecular weight proteinase inhibitors (Sottrup 
Jensen, 1989). Buffalo a2M was also inhibitory towards chymotrypsin (pH 8.0), trypsin 
(pH 8.0), pronase E (pH 8.0), proteinase K (pH 8.0) and bromelain (pH 6.8). Proteinase 
inhibition by buffalo a2M was tested using the high molecular weight substrate casein 
(Kunitz, 1947). The buffalo a2M also protected the amidolytic activity of the above 
enzymes against inhibition by SBTI (Table 4.3). 
4.2.6 Reactivity of Thiol esters - Presence of thiol esters is a characteristic feature of 
the proteins of aM family (Sottrup-Jensen et al., 1980). The number of trypsin or 
methylamine sensitive thiolester present in a2M can be determined by the quantitation of 
free thiols released after the treatments. Native buffalo a2M contained no free 
sulphydryls. Trypsinization released 4 mol of thiols per mole of a2M while those 
liberated in response to methylamine treatment were only 2 (Table 4.4) 
4.2.7 Stoichiometry of Inhibition of Trypsin - The stoichiometry of the association 
of buffalo a2-macroglobiilin with trypsin was determined by reacting the inhibitor with 
increasing concentration of trypsin and determining BAPNA-lytic activity of the 
entrapped trypsin in presence of excess SBTI. As shown in Fig. 4.11, the stoichiometry 
FABl E 4.2 
Effect of aninei en the activity of buffalo ajM 
Treatment 
None 
Methylamine, !0h 
Methylamine, 24h 
Butylamine, K'h 
Butylamine, 24h 
a:M Activit}' (units) 
.60 
0,78 
Activity retained (%) 
100 
49 
Bach value ni]:resent the mean of three independent experiments performed in triplicate. 
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TABLE 4.3 
Prote:fiase irhibition by buffalo azM 
Prols nase 
Broini;!ain 
Chymotrypsin 
Proriase 
Proteinase K 
Tp'psin 
Inhibition 
i'rotiiolytic inhibitory activity 
++ 
++++ 
++ 
+++ 
Amidolytic activity 
n.d. 
Nil. 
Nil. 
Nil 
Nil 
-i 
Inhibit.ion of caseinolytic activity wa.i performed as described by Kunitz (1947). 
Amidolytic activity of proteinase u.-irg BAPNA as substrate in presence of 0.2M was 
determined by Ganrot (1966). 
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TABLE 4.4 
Thiol 2;roup content of na.:ive, trypsin or methylamine treated azM 
Treatment 
None 
Tiypisin 
Methylamine 
Methylamine tciHcwed by tiypsi 
2.010.05 
4.1 ±0.09 
Native, trypsi'i or methylamine irea':ec a2M vva.s titrated with DTNB as described under 
methods and i:hani2e in ;:.bsorbai:ce was monitored at 410 nm. 
Each value repi'esent the mean ofthree independent experiments performed in triplicate. 
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Figure 4.10 Effect ofmethylamine on buffiilo a2M 
PAGE v».as performed or 5% non-denaturing gel as described under the 
method? section. Buffalo ai.M was treated with 0.5M methylamine, pH 
8.0 for 24h at 22*'C as described in the methods. Part of the preparation 
was treaied v/ith 2-fold molar excess of trypsin at ST^ C for 10 min and the 
reactio)-. Terminated by tne addition of ImM PMSF. Lane a, contained 
native c )M while lane b ant c contained methylamine treated and 
methyl;;.fainc: followed by trypsin treated aaM. Each lane contained 15-20 
ug of protein respectivel) . 
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Figure 4.11 Bindiric site Titration of buffalo a^M 
Buffalo 1X2M (().]8 nmoles) vva:; incubated with various concentrations of 
trypsin .:n 'OmM sodium phosphate buffer, pH 8.0 at 37°C for 15 min. 
This wa; followed by addition of 0.^5 nmoles of SBTI and incubation at 
1<1^C for another 15 min. The amount of trypsin protected from SBTI by 
o.jM wa: assayed bj' the addition of BAPNA as described in the methods. 
The p(:r::en!age of maximal activity is defined as the ratio of esterase 
activit;, :br a given tiyp^in • C'.2M ratio divided by the highest esterase 
activity :ou;id for tn,psin aiM in this .study (Hudson et a!., 1987). 
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0.2 0.^ 0.6 0.8 1.0 
Trypsin/o(2 macroglobulin molar ratio 
1.2 
of inhibition of trypsin showed that each mole of intact buffalo a2M entrapped 1.0 mol of 
tliie enzyme. The value was thus lower than that of the human inhibitor which can entrap 
upto 2.0 mol of proteinase per mole of a2M. 
4.2.8 Carbohydrate Composition - a2Ms from a variety of sources are glycosylated to 
various extents and buffalo a2M was no exception with a total hexose content of 7.8%. 
ITiis value is lov^ er than the human a2M, that contains 9.43% carbohydrate (Dunn and 
Spiro, 1967). 
4.2.9 Amino acid composition - The concentration of each amino acid was estimated 
by measuring the area of the respective peak by matching it with the standard amino acid 
pieak (Fig 4.12). The data for the amino acid composition of buffalo a2M (Table 4.5) 
shows good similarities, with the a2M's of goat, mouse and human plasma. 
Concentration of each amino acid was estimated by measuring the area of the respective 
pieak by matching with the standard amino acid peak (Fig. 4.12 a & b). The buffalo a2M 
is however significantly deficient in proline and aspartic acid, but rich in alanine as 
compared to goat, mouse and human inhibitors. 
4.2.10 Cross reactivity - Buffalo a2M was quite immunogenic and readily induced 
antibody formation in rabbits. Fig 4.13 shows that antisera raised against purified buffalo 
CI2M readily cross reacted with goat and human a2M as indicated by the formation of 
jffecipitin lines. 
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Figure 4.12 (a) Standerd Amino ;»cid spectra. 
(b) Amino acid compcsitiori spectra of buffalo a2M. 
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lABI.E 4.5 
Amino add composition oJ the purified buffalo, goat, mouse and human a2M 
Amino acid 
Asp 
Thr 
Ser 
Gin 
Pro 
Gly 
Ala 
Cys 
Val 
Met 
He 
Leu 
Tyr 
Phe 
Lys 
His 
Arg 
Trp 
C 
Buffalo a2M' 
6.92 
5.52 
8.89 
11.49 
om position (mol/100 mol of residues) 
Goat a.M" 
8.18 
7.59 
10.58 
11.50 
3.88 i 6.07 
7.4S 
8.J5 
1.20 
9.04 
1.63 
4.69 
9.80 
3.90 
4.17 
6.57 
2.S6 
3.90 
1.13 
6.87 
6.04 
2.07 
8.56 
1.13 
3.62 
8.42 
3.60 
3.56 
5.95 
1.95 
3.60 
0.58 
Mouse a2M'^  
9.56 
6.28 
7.97 
11.54 
4.87 
5.90 
5.62 
Human aiM'' 
7.95 
6.75 
8.35 
12.25 
5.25 
6.20 
6.35 
1.22 ^ 1.61 
8.34 9.45 
1.53 1.72 
5.44 
9.65 
3.19 
4.20 
5.85 
4.87 
3.00 
1.03 
3.93 
9.25 
3.86 
4.27 
6.14 
2.69 
3.86 
0.76 
The results arc based on Mr value of 660,000 for buffalo a2M. 
Sample [Img] was hydrolysed f )r 24 hrs at 110°C under vacuum in 6 N HCl predistilled 
with constant boiling, .^mino acid compositional analysis was carried out on Beckman 
121 M analyze! • 
9 Trp was calculated by the method of Heaven and Holiday (1952) 
a. This study 
b. Unpublished data of Dr, Fah,m. H. Khan (1996) 
c. Hud.sonei'n/. (1987) 
d. Dunn and Spiro (1967) 
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Figure 4.13 Ouchieriony Immunodiffusion 
Antiljuffalo ajM antisera were raised in albino rabbits. The 
immunodiffusion of antibufJalo a-iM antisera was allowed to react with 
bufrc:o and human rx2M in agarose gel as described in the methods 
sec;ii:n. The central v.'ell contained antibuffalo a2M antisera and well 1, 2 
and : contained buffalq,and Jiuman aaM respectively. 
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4.3 DISSOCIATION OF NATIVE AND MODIFIED ALPHA-2-
MACROGLOBULIN BY SODIUM THIOCYANATE (NaSCN) 
4.3.1. Effect of NaSCN on ajM 
Sodium thiocyanate is a chaotropic agent which causes the disruption of 
hydrophobic forces. When native a2M was incubated for 60 min with increasing 
concentration of NaSCN, the process of dissociation to dimers became significant once 
the concentration of the sah equals 1.2 M. The proportion of a2M half molecules 
increases with further increase in the concentration and at 2.0 M NaSCN most of the 
inhibitor was in the form of dimers (Fig. 4.14). The dissociation into dimers was not 
readily reversible as relowering of NaSCN the concentration to 0.2 M resulted in no 
major increase in the fraction of tetrameric molecule. 
4.3.2. Effect of NaSCN on methylamine modified a2M 
a2M treated with methylamine (a2M-MeNH2) was more resistance to dissociation 
by NaSCN. Significant dissociation of oi2M-MeNH2 was apparent only at 1.4 M NaSCN 
and even at higher concentration of NaSCN the proportion of the half molecules formed 
firom a2M-MeNH2 was lower than that obtained from the native a2M (Fig. 4.15). 
4.33. Stokes radius 
Native a2M has a F^ okes radius of 85°A. The elution profile of the a2M half 
molecules obtained by dissociation of a2M with 1.6 M NaSCN gave a Stokes radius (Re) 
of 65.2 "A. The Re of the half molecules obtained by dissociation of a2M by NaSCN was 
comparable with that obtained by dissociation of a2M with 4M urea (Re = 67.2°A) as 
given in table 4.6. 
43.4. The effect of NaSCN on the intrinsic fluorescence of a2M 
Intrinsic fluorescence of protein is contributed by three fluors -tryptophans, 
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Figure 4.14. Gel i;lectrophoretic analysis of the dissociation of buffalo a2M by 
sodium fhiocyanate. 
Electj'jplioresis was perforrr;ed on 5% non-denaturing gel as described 
under methods section. The effect of incubation with different 
concentrations of NaSCN for 60 min at 22°C. The salt concentrations are 
in lanes : a, zero, b, 1.0 M; C, 1.2 M; d, 1.4; e, 1.6 M; and f. 2.0 M, Lane g 
contains half-molecules obtained by incubation of ajM with 1% SDS for 
90 nun at 22T'. All lanes contain 25 jag protein. 
VO 
^•^' Y^XmX IpJ ^ • . y»J :j^< 
Q b c d e f g 
igure 4.15. Polyacry l.iniide Gd electijphorcsis of the dissociation of methyiamine 
modified o.iM by sodium thiocytnate. 
Electrophc *esis wa;; performed on 5% acrylamide gel as described under 
methods. The effect O' incubation of a2M-MeNH2 with different 
concentri;t;on,s of NaSCN for 60 min at 22°C. Lanes: a, a2M; b, aaM-
methylaniine. The salt conoentrat ons in lanes are : c, 1.2 M; d, 1.4 M; e, 
1.6 M and i", 2.0 M. Lane g. contains half molecules obtained by 
incubation of a2M with \% SD3 ibr 90 min at 22°C. All lanes contain 25 
(ig protei'i 
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TABLE 4.6 
Tim stoke's radii, (lie), of buffalo aiM and a2M half molecule 
Tr'eatn!<;nt Re("A) 
None 85.0 
4M urea 67.2 
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ityrosine and phenylalanine. Excitation at 295 nm results primarily in tryptophan 
fluorescence, but with minimal interference from tyrosine, whereas excitation at 280 nm 
is the cumulative result of tryptophan, tyrosine and phenylalanine fluorescence. 
When native aiM and a2M-MeNH2 were incubated for 80 min. with 1.6 M 
NaSCN and excited at 280 and 295 nm (Fig. 4.16 & 4.17) the relative fluorescence 
decreased. The observed small red shift in the emission maximum for native and 
methylamine modified aiM after 80 min. probably indicates that the environment of the 
tryptophan, tyrosine and phenylalanine involved is slightly less hydrobhobic in a2M half 
molecules than in a2M. 
The cur/es in Fig. 4.18 and 4.19 depict the rates of dissociation of native and 
methylamine treated a2M induced by incubation with 1.6 M NaSCN. The rate of change 
in relative fluorescence at 340 nm when A.ex = 295 and 280 nm, was measured. These 
dissociation were 7.46 ± 0.26 x 10"^  s'' and 3.26 ± 0.07 x 10"^  s'' for native a2M and 
a2M-MeNH2 at X,ex = 295 nm respectively. The curve for native a2M and a2M-MeNH2 in 
Fig. 4.1$ shows that 90% of the final change in fluorescence (AF max) was reached in 50 
min at 295 nm. The fluorescence changes at 280 nm was slower and required nearly 80 
min for completion (Fig. 4.18). The first order rate constant for native a2M and a2M-
MeNH2 at 7^^ = 280 nm as calculated fi-om the data in Fig. 4.18 is 9.48 ± 0.06 x 10"^  s'' 
and 4.5 ± 0.25 x 10"^  s"' respectively. The k (rate constant) for native a2M is thus almost 
2 times higher for a2M than a2M-MeNH2 when excited either at 295 or 280 nm. 
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Figure 4.16. Intrinsic fluorescence of a2M and a2M-MeNH2 on incubation with 
sodium thiocymate. 
The intrinsic luorescence of a^M and a2M-MeNH2 on incubation with 
1.6MNaSCNat22°C. The wavelength of excitation, (?Lex), was 280 nm 
and the emission spectra between 320 and 360 nm were collected at zero 
time and after 80 min, with the time of mixing the solutions of a2M and 
NaSCN taken as zero. The concentration of a^M and aiM-methylamine 
in the curette was 0.2 mg/ml. The sUt width was 10 nm for the excitation 
and emission beam, respectively. The spectra for the following are shown 
by 
( — ) a^M at zero time 
( )a2M after 80 min 
(- • -) aiM- MeNH: at zero time 
( ) a:M- MeNH: after 80 min. 
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Figure 4.17. Tryptophanyl fluorescence of aiM and ajM- MeNH2 on treatment 
with sodium thiocyanate. 
The intrinsic fluorescence of a2M and a2M- MeNHa with 1.6 M NaSCN 
at 22''C. The wavelength of excitation, (Xex), was at 295 nm and the 
emission spectra between 320 and 360 nm were collected at zero time and 
after 80 min, with the time of mixing the a2M and NaSCN; a2M- MeNHa 
in the cuvette was 0.2 mg/mJ. The slit width was 10 nm for the 
excitation and emission beam, respectively. 
( — ) a2M at zero time 
( )a2M after 80 min 
(- • -) a2M- MeNH2 at zero time 
(-—) a2M- MeNH: after 80 min. 
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Figure 4.18 The rutt of iliange in the relative fluorescence (AF) of ajM and ajM-
McNHi at 340 nm (m incubation with 1.6 M NaSCN at 22°C at 280 
nni. 
(o) a:,M 
(•) a.M-MeNH: 
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Figure 4.19. The Tuttt of change in rehitive fluorescence (AF) of aiM and a2M-
MeNMxaf 340 nm on incubation with 1.6 M NaSCN at ZZ^C The data 
at 295 nm. 
(o) OjM 
(•) OiM-MeNH. 
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4.4. EFFECT OF ZINC ON STRUCTURE AND FUNCTION OF azM 
4.4.1. Plasma and ajM zinc concentration 
The physiological zinc concentration of buffalo plasma determined by the method 
of Song et al. (1976) was in the range of 18 - 20 i^M. The purified buffalo a2M contained 
400 ng Zn/g (6g-atom zinc) of protein. Irreversible binding of zinc by the a2M was also 
estimated after treatment with 30 nM and 200 i^M zinc for 1 h at 4^  C. Prior to zinc 
analysis this preparation was extensively dialysed against 20 mM Tris buffer, pH 8.0 in 
order to remove the loosely bound metal zinc. The zinc content of the sample incubated 
with 30 |iM and 200 ^M zinc was 1,055 jig and 3,800 |ig/g of protein, respectively. 
4.4.2. The Effect of zinc on trypsin binding activity of a2M 
The effect of zinc on trypsin binding activity of the buffalo a2M is shown in Fig. 
4.20 the trypsin binding activity of a2M does not depend on the presence of zinc since all 
but traces of this metal can be removed by EDTA without significant loss of the trypsin 
binding. Incubation with higher concentration of zinc however interfered with trypsin 
binding activity. At 30 g-atom Zn/g, over 50% of trypsin binding activity was lost and 
when the concentration was 58g-atom Zn per/g a2M practically all binding activity 
disappeared. Exhaustive dialysis of a2M samples incubated with higher concentrations of 
zinc against 20 mM Tris buffer, pH 8.0 containing EDTA did not restore its trypsin 
binding activity. 
4.4.3. EFFECT OF ZINC ON THE CONFORMATION OF a2M 
4.4.3.1. Gel Electrophoresis 
Trypsinization of the native buffalo a2M resulted in the characteristics "slow" to 
"fast" transformation in electrophoretic mobility. The inhibitor pre-treated either with 
30 nM or 200 ^M zinc also exhibited the transformation (Fig. 4.21). Incubation with 
zinc at either concentration also did not alter the response of the buffalo aiM 
methylamine treatment. The treatment resulted only in small increase in electrophoretic 
mobility (Fig. 4.22). 
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Figure 4.20. Effect of zinc on the ttypsin binding activity of ajM. 
To six of a series of 9 tubes each containing (2 mg/ml with a zinc content 
of 5 g-atoms Zn/mol), solution of ZnCb was added to make a final 
concentration of about 10, 30, 100, 200 and 500 ^M and the trypsin 
binding activity measured. The remaining 3 tubes were dialyzed for 48 h 
against 1, 5 and 10 mM EDTA respectively in 20 mM Tris buffer, pH 8.0 
and the zinc content of a2M as well as trypsin binding activity determined. 
- The bar in the graph represent g-atoms Zn/mol of a2M 
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Figure 4.21. Effect of trypsin on native and zinc treated a^M. 
Electrophoresis was perforrnej on 5% acrylamide gel as described under 
method section. Buffalo a^M treated with zinc was reacted with 3-fold 
molar excess of tiypsir, at iT^C for 10 min and reaction was stopped by 
additicifi of ImM PMSf. Lan^ a, c. and e contains native, 30 |aM and 200 
I^ M 2\ac i:reated aiM respecti\/ely. Lane b, d, f contains there trypsinized 
forms respectively. All lanes contain 20 |ig protein. 
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Figure 4.22. Effect of methylamine on native and zinc treated a2M. 
PAGE was performed on 5% gel as described in the methods section. 
Buffalo a2M and zinc reacted a2M was treated with 0.5 M methylamine, 
pH 8.0 for 24 h at 22°C as described in text. Lane a, contained native 
a2M; Lane c, a2M treated with 30 j^ M zinc; Lane e, 200 |iM zinc treated 
a2M; Lane b, methylamine treated form of native a2M; Lane d and f 
contains methylamine reacted form of 30 |iM and 200 |aM zinc treated 
forms respectively. 20 (ig of protein was applied in each lane. 
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4.4.3.2. Intrinsic Fluorescence 
The corrected fluorescence emission spectra obtained for buffalo aaM alone gives 
emission maximum at 333nm (Fig. 4.23) when excited at 280nm. Reaction with 
methylamine caused a 3mn blue shift of the emission maximum and was accompanied by 
a small enhancement in the fluorescence. Treatment with Sepharose-linked trypsin 
resulted in 2nm red shift with 50% decrease in the magnitude of fluorescence. 
To observe tryptophanyl fluorescence, native a2M was excited at 295nm. This 
resulted in an emission maximum at 339nm. As compared to native a2M, methylamine 
treated a2M showed a 3nm blue shift with no significant change in magnitude of 
fluorescence. Native inhibitor on reaction with immobilized trypsin responded with a 
2nm blue shift but with 28% decrease in fluorescence as shown in Fig 4.24. 
In order to study the effect of zinc on the methylamine and trypsin induced 
alteration in the tertiary structure the modified a2M was excited at 280mn. a2M treated 
with 30|aM zinc retained nearly 80-100% activity showed conformational alterations 
comparable witli those of native a2M (Fig. 4.25). Treatment with 200 ^M zinc however, 
resulted in inactivation of a2M and the a2M pretreated thus exhibited 30% quenching 
indicating specific conformational changes in the molecule on binding of zinc. 
Treatment with methylamine resulted in 18-20% enhancement in fluorescence with a 
3nm blue shift in emission maxima whereas 3nm red shift wa-j observed with Sepharose-
linked trypsin with 25% quenching (Fig. 4.26). 
4.4.3.3. Circular dichroism of native and zinc treated alpha-2-macrogIobulin 
4.4.3.3.1. Circular dichroism spectra in far-U.V. region 
The spectra for native a2M is characterized by the presence of a minima at 216 
nm with a shoulder around 213 nm. Reaction of the inhibitor with methylamine resulted 
only in marginal alteration in the spectrum while, Sepharose-linked trypsin caused very 
marked decrease in the mean residue elUipticity (Fig. 4.27). 
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Figure 4.23. Intriiiiie lluorescence of a^M and a2M treated with methylamine and 
Sephiii osj; linked trypsin. 
Correcfi^ J lluorescence spectra of buffalo a2M alone and a2M reacted 
v/ith msthylamine and Sepharose linked trypsin ( ) aiM alone; 
(•— • - - j a2M reacted with methylamine; ( ) a2M reacted with 
Sepharjse-linked tryps-a. The conditions of the reactions are given in 
methcci section. The cx.citalion wavelength was 280 nm, and bandwidth 
was 1'.) am in both channels. The a2M concentration was 0T8 jiM. 
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Figure 4.24. Intrinsic fluorescence of native ajM and aiM reacted with 
methylamine and immobilized trypsin at 295 nm. 
Corrected fluorescence spectra of aaM alone and a2M reacted with 
methylamine and Sepharose-linked trypsin. ( ) aaM alone; ( ) 
a2M reacted with methylamine; ( ) a2M reacted with immobilized 
trypsin. The conditions of the reactions are given in methods section. The 
excitation wavelength was 295 nm, and bandwidth was 10 nm in both 
channels. The a2M concentration was 0.18 fiM. 
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Figure 4.25. Fluct;!>cence spectra of naive and 30 \iM zinc pretreated aiM on 
reaclinn tvith jiieKhylamin? and Sepharosc-linked trypsin. 
F-luoi€:5cence spectra of ( ) a;.M alone; (— • —) aiM reacted with 
meth;/lan',ine; ( -- ) ujM reacted with Sepharose-linked tr>'psin; (— ••• 
— ) .'•() laM zinc reacted a^ .VI; ( ) 30 |iM zinc reacted a2M on 
methylamine treatmen;.: (— •• — ) 30 f.iM zinc reacted a2M treated with 
Sepb arose-linked tn/p:;:.n. The excitation wavelength was 280 nm, and 
band'A dth was 10 nm ,n both channels. The concentration was 0.18 |iM. 
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Figure 4.26. Fluoniscerice specira of nafho and 200 )J.M treated buffalo a2M on 
reactidii with methylamine and Scpharose-linked trypsin. 
( ] a2M alcne; (— —) a.iM reacted with methylamine; ( ) a2M 
reacted with Sepharose-iinked trypsin; ( — ••• — ) 200 jiM zinc reacted 
o-iM; ( ) 200 |iM drc reacted a2M on methylamine treatment; 
(— •• —• ) 200 pM z nc reacted with Sepharose-linked trypsin. The 
conditoris of the reactions are given in methods section. The excitation 
wavel:;ngth was 280 nni, and bandvvidth was 10 nm in both channels. The 
(X2M c;):i;:enTration was (.18 uM. 
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Figure 4.27. Far-UV circular dichroism spectra of buffalo CX2M on treatment with 
methyiiiniine and immobilized trypsin. 
a.iM alone and buffalo UjM reacted with methylamine, or immobilized 
trypsin r ) a^M alone; (• ) (XjM reacted with methylamine; a2M 
reacted 'vith immobilized tryps n ( —). The conditions of the reactions 
with methylamine and liypsin were as given in methods. Cells with 0.1 
cm path length and an a^M concentration of 0.5 |iM were used. 
Meth) lamine of the .same concentrations as in the sample was included in 
the bl;;.rK. The unit on the ordinate is mean residue ellipticity. The mean 
residue weight for buffalo a^M was calculated to be 110 from amino acid 
analysi' 
{'.7 
205 X (nm ) 2 50 
a2M treated with 30|iM zinc exhibited a CD spectrum comparable with that of 
native a2M. The alteration induced by methylamine and trypsin were also comparable 
(Fig. 4.28). Reaction of a2M with 200 fxM zinc however, causes a marked change in the 
shape of the circular dichroic spectrum. While methylamine treatment caused a small 
increase in ellipticity, treatment with Sepharose-linked trypsin resulted a significant 
change in the shape of the aaM CD spectrum (Fig. 4.29) with 25 % decrease in the mean 
residue ellipticity. 
4.4.3.3.2. Circular dichroism in the Near-U.V. region 
The circular-dichroic spectra in the near U.V region reflects the contribution of 
aromatic side chains, disulphide bonds, and of prosthetic groups (Kuwajima, 1989; 
Dryden and Weir, 1991). Figure 4.30 shows the near-UV CD spectra of buffalo a2M in 
250-300 nm range. Near-UV CD spectra of native a2M is characterized by a band at 
282 nm showing the asymmetric environment of tyrosine. Methylamine and Sepharose-
linked trypsin treated buffalo a2M showed dissimilar near UV CD spectra. A small 
value of MRE at 282 nm on treatment with Sepharose-linked trypsin indicates the 
absence of ordered structure whereas for native and methylamine treated a2M a more 
ordered tertiary structure was observed (4.30). 
There was no change in the CD spectral band of a2M pre-treated with 30 i^M 
zinc on reaction with methylamine and proteinase (Fig. 4.31). On the other hand a2M 
treated with 200 |JM showed subtle changes with respect to native a2M, although the 
changes induced in the wavelength region around 280-290 nm were markedly different 
both for methylamine and Sepharose linked trypsin treated a2M (Fig. 4.32). 
4.4.4. Dissociation of a2M by Zinc 
The inhibitory activity of a2M was determined by incubating a2M with various 
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Figure 4.28. Circular dichroism spectra of 30 \iM zinc treated buffalo ajM on 
reaction with methylamine and Sepharose-Iinked trypsin in the 
peptide region. 
( ) 30 |iM zinc treated aaM; ( ) zinc treated a2M reacted with 
methylamine; ( ) zinc treated a2M reacted with immobilized trypsin. 
The condition of the reactions with methylamine and trypsin were given in 
methods. Cells with 0.1 cm path length and an a2M concentration of 0.50 
|aM were used. Methylamine and zinc of the same concentration as in the 
sample were included in the blanks. The unit on ordinate is mean residue 
ellipticit)'. The mean residue weight for buffalo aaM was calculated to be 
110 from the amino acid analysis. 
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Figure 4.29. Circular dichroi.sm spectra 20D |iM zinc pretreated a2-macroglobuiin 
and th<:ir derivatives. 
CD spectra (205-25() nm) of" 10) |iM zinc treated ai-macroglobulin, 0.35 
mg/ml. ( ) zinc reacted ajM; (— ) zinc bound a2M reacted with 
methylarriine; ( ) ;-.inc bc^ und CQM treated with Sepharose linked 
trypsin Cells with 0.1 i;m path length were used. The Mean Residue 
ellipticit/ has been calculated with MRW of 110 calculated from amino 
acid analvsis. 
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205.0 A (nm ) 250.0 
Figure 4.30, Near-U.V. circular ilichroisni spectra of buffalo a2M and aiM treated 
with miilhylamine and wSoph -^rcse-linked trypsin. 
( ) ;ti)M alotie; (— • —) (t^ M allowed to react with methylamine; 
( ) a2M allowiid tc react, with Sepharose-Hnked trypsin. Cells with 
1 cm pc.ih length and :in o-jM con:;entration of 1.0 \iM were used. 
Methyl;;,riiine of the same conce.itration as in the sample was included in 
the blank. The unit on the ordinate is mean residue ellipticity. 
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25 0.0 A(nm ) 300.0 
Figure 4.31. Circular dichroism spectra of 30 jiM zinc treated a2M on reaction 
with rntthylariaine and Sepharose-linked trypsin in the aromatic 
region. 
( ) 30 |.iM zinc trealed a^M; (— • —) 30 ^M zinc reacted a^M 
treal-;; vnth methyiamine; ( ) 30 \xM zinc treated a2M on reaction 
vv'ith l-epharose-linkec: trypsin. Cells with 1 cm path length and an aiM 
concentration of 1.0 I'.M vvere used. The unit on the ordinate is mean 
residee ellipticity. 
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Figure 4.32. Aroir.atie circular dichroisni spectra and 200 i^M zinc treated a2M on 
react on •with methylamine and Sepharose-Iinked trypsin. 
( ) 200 |iM zinc treaied aiM; (— • —) 200 |iM zinc reacted a2M 
follc\.ed by reaction v/ith methylamine; ( ) 200 ^M zinc pre-treated 
a2M on reaction v/ith Sepharose-linked trypsin. Cells with 1 cm path 
length and a2M concentration of 1.0 \xM were used. The unit on the 
ordinate is mean residue eliipiticit)-, 
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300.0 
concentrations of zinc for 24 h at room temperature. With the increase in zinc 
concentration the inhibitory activity of a2M decreased. Fig. 4.33 shows that at a zinc 
concentration of 100 jxM, there is a 50% decrease in ajM activity. Controls showed that 
tlie observed a2M activity decrease was not related to the effects of zinc on the activity 
of trypsin. 
The result in Fig. 4.34 demonstrates that when the native buffalo a2M incubated 
for 24 h with zinc concentration up to ImM at room temperature, the protein starts 
dissociating into half molecules. Complete dissociation was not observed even at ImM 
zinc concentration after 48 h incubation. Molecules obtained by incubation of a2M with 
1% SDS for 90 min. at 22°C was used as control as marker for tetrameric and dimeric 
forms of a2M. 
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Figure 433. Inhibitory activity of a2-macroglobuliii in the presence of zinc. 
a2-macroglobulin samples incubated with divalent cations were asss^ed 
for activity as described under methods. a2M activity is expressed as a 
percentage of the activity measured in the absence of added cation. 
(• ) a2M inhibitory activity in the presence of zinc. 
(o) Control. 
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Figure 4.34. Non-denaturing gel elecfrophoresis of a^ M incubated with zinc. 
The efie<;t of incubation (tf a^M with different concentration of ZnClz for 
24 h at room temperature. The cation concentration are Lane a, zero; Lane 
b, 25 ^\v[; Lane c, 50 i^M Lane d, 100 ^M; Lane e, 500 |aM; Lane f, 1000 
fiM. L;;.n2 g. a2M incubated v/it'i 1% SDS for 90 min at room temperature 
as markers for the position of tetramer and dimer of a2M respectively. 20 
jig of pic;ein were applied in each lane. 
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4.5 Discussion 
Alpha macroglobulins are ubiquitous proteins that occurr in diverse animal 
species, including the vertebrate and invertebrates (Starkey, 1982; Quigley and 
Armstrong, 1983a;b). The physiological roles of a-macroglobulins are indeed 
challenging and engrossing. The unusual mechanism of proteinase inhibition by a2M has 
attracted remarkable attention and led to its purification and characterization from a 
variety of sources (Table 1.1). Extensive work is currently being carried out on various 
aspects of a2M and several isolation procedures are available. Earlier study from this 
laboratory has shown that caprine a2M is unique in several aspects and some of these 
characteristics were attributed to the special cleaved subunits (Khan et al., 1999). 
The present study involves purification and characterization of ajM from buffalo 
(Bos indicus) blood plasma. The purification of this proteinase inhibitor was achieved 
using ammonium sulphate fractionation and gel filtration chromatography. A high 
recovery of 61% with 35-fold enrichment in specific activity is the advantage of this two 
step scheme of aaM purification (Table 4.1). Homogenity of the aaM preparation was 
confirmed by the presence of single band in pore-size electrophoresis (Fig. 4.2). 
Purification to homogeneity of human plasma a2M normally requires additional ion-
exchange step (Mirza and Saleemuddin, 1993). The ease of purification of a2M from 
buffalo plasma is apparently related to the absence of large molecular weight 
contaminating proteins. The native inhibitor behave like a homotetramer and on treatment 
with SPS and p-mercaptoethanol migrated as a single band on 7.5% SDS-PAGE (Fig. 
4.4). Like its human and bovine homologue (Dunn and Spiro, 1967; Nagasawa et al. 
1970) buffalo a2M is also glycosylated with 7.8% carbohydrate. 
Various studies using SDS-gel electrophoresis, gel filtration chromatography and 
sedimentation equilibrium have estimated the molecular weight of the tetrameric a2M in 
the range 700-800 KDa (Schultze etal, 1955; Schonenberger etal, 1958; Roberts, 1986; 
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Nagasawa el al., 1970; Hudson and Koo, 1982). The molecular weight of the buffalo 
a2M as determined using a Sephaciyl S-300 HR column was 660 KDa (Fig. 4.6). The 
value is lower than that of human a2M (Halls and Roberts, 1978) but comparable with 
the caprine aiM (Khan et al, 1999). Moreover, the Stokes radius of a2M also confirms 
the buffalo a2M to be more compact than that from human plasma. The value was 85°A 
(Fig.4.7) as compared to the reported value of 88° A of the human a2M (Roberts, 
1986). 
Purified buffalo a2M when subjected to gel electrophoresis in the presence of 
SDS and P-mercaptoethanol yielded, a single band (Fig. 4.5). The molecular weight of 
the subunit of a2M determined in this study gave a value of 165 KDa whereas, human 
a2M migrates as a single 185 KDa band (Sottrup-Jensen, 1989). Inspite of its similarity 
in molecular dimensions the buffalo a2M differed from its ruminant counterpart (i.e. 
caprine a2M) in the nature of subunit. The caprine inhibitor is a tetramer of 146 KDa 
subunits which intum are made up of two disulfide linked 110 and 36 KDa peptides 
(Khan et al., 1999). The occurrence of cleaved subunits have also been reported in other 
species (Hudson et al., 1987) and has been ascribed to the post translational processing of 
the peptide. Bovine a2M however has an intact subunit of 185 KDa. The difference in the 
nature of the subunit in very closely related species may indicate lack of clear 
evolutionary trait but suggests abrupt specific adaptation. 
Trypsinization of buffalo a2M lead to increased mobility in pore limit and rate 
electrophoresis in 5% acrylamide gels (Fig. 4.8). This is similar to the characteristics 
"slow" to "fast" transformation of human a2M on trypsin treatment (Barrett et al, 1979; 
Nelles et al, 1980). Sepharose-linked trypsin was capable of bringing about the 
transformation of a2M to the "fast" form albeit at a slower rate (Fig. 4.9) indicating that 
immobilization process does not abolish the bait region cleaving ability of the proteinase. 
It has been sho^ tvn that treatment of human a2M with solid support attached trypsin 
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results in the formation of empty traps that resemble the trypsin treated forms in several 
respects (Mirza and Saleemuddin, 1993). Similarity in the nature of a2M transformation 
induced by soluble and immobilized chymotrypsin has been demonstrated by image 
processing of the electron microscopy (Biosset et a/., 1991a;b). 
aMs from a variety of sources function as "molecular traps" for broad spectrum 
proteinases (Barrett and Starkey, 1973) rather than as inhibitors (Sottrup-Jensen, 1987; 
Sottrup-Jensen, 1989; Roberts, 1986). Buffalo a2M appears to be no exception and 
exhibits inhibitory activity and protection of amidolytic activity to trypsin (pH 8.0), 
chymotrypsin (pH 8.0), pronase E (pH 8.0), proteinase K (pH 8.0) and bromelain (pH 
6.8) as shown in Table 4.3. This is apparently related to the presence of susceptible 
bonds in the bait region of the molecule. 
It is evident from several studies that the reaction of a2M with methylamine is a 
complex phenomenon involving random attack on the thiolesters (Feinman, 1983; 
Sottrup-Jensen, 1987; Strickland and Bhattacharya, 1984; Larson et al., 1985). Incubation 
of buffalo ttiM with methylamine, resulted only in a very small increase in 
electrophoretic mobility (Fig. 4.10). Nearly half the original activity of buffalo a2M is 
retained by the a2M after treatment with methylamine (Table 4.2). This suggests that the 
thiol esters of buffalo a2M are more stable to nucleophilic attack by methylamine than 
those of human a2M (Gonias et al., 1982). Somewhat similar behaviour is shown by 
bovine and caprine inhibitor (Nagasawa et al, 1970; Khan et al., 1999). It is interesting 
to note that the methylamine treated human a2M is completely devoid of the ability to 
inhibit or entrap proteinase (Gonias et al., 1982), while the inhibitory activity of equine 
a2M remains completely unaffected by methylamine (Motoshima e/a/., 1988). 
The numiber of methylamine or trypsin sensitive thiol esters present in buffalo 
a2M was deterwiined by the quantitation of the number of excess free thiols generated as 
a result of these treatments. Methylamine liberated only 2 moles of thiols per mole of 
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a2M while those liberated in response to trypsin treatment were 4 (Table 4.4). Although, 
buffalo a2M like its human and bovine counter part has 4 moles of thiol ester per mole 
but the accessibility of two among these seems to be restricted even to low molecular 
weight molecule i.e. methylamine. Although the physiological significance of the 
presence of thiol esters of unequal reactivity is difficult to predict, their occurance has 
also been reported in caprine a2M (Khan et al, 1999). Trypsinization of methylamine 
pretreated a2M caused further release of two thiol esters and converted the intermediate 
mobility species to "fast" from on 5% gel (Fig. 4.10). 
In human a2M the structural constraints released by the thiol ester cleavage are 
transmitted to the other parts of the molecule, ultimately causing perturbation in the thiol 
ester domain of the adjacent subunit and the increase in the accessibility of thiol esters to 
methylamine (Gonias et al, 1982 Dangott et a/., 1983). Apparently these exert an 
(^posite effect as in buffalo a2M and conformational changes occuring as a result of 
cleavage of two thiol esters restrict the accessibility of the remaining two esters. 
Alternatively, the recalcitrance of two thiolesters of buffalo a2M may result from their 
location in deep hydrophobic cleft in manner that makes them inaccessible even to small 
molecular weight amine. 
The stoichiometry of inhibition of trypsin showed that 1.0 mole of intact buffalo 
a2M entrapped a maximum of 1.0 mole of enzyme i i; shown in Fig. 4.11 which is lower 
than that of human inhibitor. This behaviour may be related to the structural features of 
buffalo a2M that promote a higher extent of non-productive activation by cleavage of the 
bait region before binding of proteinase (Ganrot, 1966) or due to smaller dimensions of 
the buffalo inhibitor (Fig. 4.7). 
The amino acid composition of buffalo a2M bore remarkable similarities with 
those of human, goat and mouse a2Ms (Duim and Spiro, 1967; Hudson et al., 1987; Khan 
etal, 1999). The concentrations of Asp, Thr and Pro were lower significantly while those 
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of Gly and Ala were higher (Table 4.5). The similarities are also reflected in the cross 
reactivity of the anti-buffalo a2M with goat and human aaM (Fig 4.13). 
The dimer-dimer interactions in the tetrameric a2Ms play an important role in the 
trapping of proteinase and regulation of conformational changes that accompany 
proteolytic attack (Jensen, 1993). The tetramerization of a2M may have functional 
implications on the biological functions of the inhibitor, which may involve the 
simultaneously evolved contact zone. The significance of the contact zone has been 
emphasized for human a2M (Shanbhag et al, 1997). Curiosity to investigate the role of 
contact zone as a fiinctional site in non-human tetrameric a2M's led us to carry out the 
studies on the dissociation of the buffalo inhibitor. 
Dissociation of a2M along non-covalent axis by urea, guanidine hydrochloride, 
SDS, metal ions of +2 oxidation State (Zn, Cd, Hg, Cu, Ni) and chaotropic anion has 
been shown to generate half molecules (Sottrup-Jensen et al, 1980; Pochon et al, 1987; 
Pratt and Pizzo, 1984; Roche et al, 1988; Sjoberg et al, 1991; Shanbhag et al, 1996). 
The chaotropic anion thiocyanate has been used to dissociate buffalo a2M and a2M-
MeNH2 complex through non-covalent axis in this study. The result in Fig. 4.14 clearly 
shows that thiocyanate dissociates a2M into half molecules with an electrophoretic 
mobility comparable to that obtained by incubating the protein with 1% SDS (Harpel 
et al, 1979). a2M-MeNH2 dissociates at far higher concentration of thiocyanate than that 
required for native a2M (Fig. 4.15). 
It is icnown that the chaotropic thiocyanate anion modifies the structure of water 
thereby disrupts the hydrophobic interactions (Hamaguchi and Geiduschek, 1962). 
Dissociation of the tetramer in presence of NaSCN suggests the involvement of 
hydrophobic amino acids in the association between the non-covalent bonded subunits in 
a2M. The observed difference in the dissociation profile between native and methylamine 
reactive a^M is indicative of the increased interaction between the contact zone which 
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intum are also controlled by the conformational changes induced in the protein on the 
thiol ester cleavage or by cleavage of botli thiol ester and bait region. Human ajM-
MeNHa also dissociates to a lower extent than the native a2M in presence of NaSCN 
(Shanbhage/fl/., 1996). 
The Stokes radius of the buffalo a2M half molecule generated by sodium 
thiocyanate was similar to that obtained by dissociation with 4M urea (Table 4.6). 
Neither urea nor NaSCN cleave disulphide bonds (Liu et al., 1987; Shanbhag et al., 
1996). Thus, the a2M half molecule generated in this study is the likely result of the 
disruption of only the non-covalent interactions. These observations taken together 
indicate that no major conformational change may have occurred during dissociation of 
tetrameric a2M into half molecules under the conditions used and the dimers may remain 
in an undenatured state. In support of this the observed stokes radius for the fraction of 
a2M that remained undissociated on treatment with 1.6M NaSCN was comparable with 
that of native a2M (Table 4.6). 
Fig. 4.16 and 4.17 shows the difference in the intrinsic fluorescence of native 
a2M and that treated with 1.6M NaSCN. The dissociation of tetramer into half molecule 
causes a decrease in the intrinsic fluorescence with a slight red shift of the emission 
maximum, after 80 min. incubation with the anionic salt. This decrease in fluorescence 
suggest chat some conformational changes occur as a consequence of dissociation in 
which the enviroimient of the hydrophobic amino acid is altered. The dissociation of 
human a2M into half molecules induced by NaSCN results in conformational changes 
resembling those that occur to thiol ester cleavage in the inhibitor and treatment of the 
resulting half molecules with methylamine caused no significant additional 
conformational alteration (Shanbhag et al., 1997). The results shows the presence of 
aromatic amino acid residues at the contact zone and that these fluorophores are 
gradually brought into a polar environment. The fluorescence behaviour of the exposed 
aromatic amino acid of a protein may also be influenced by the composition of the 
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solvent even in the ; isence of any significant conformational changes and such effect 
have been used to probe the solvent accessibility of aromatic residues of a protein 
(Creighton, 1991.). Addition of sodium thiocyanate is known to cause an increase in the 
polarity of the solvent (increased refractive index) and hence may cause a decrease in 
fluorescence intensity and shift in emission maximum (Fig. 4.16 and 4.17). It is also 
possible that the tyrosyl hydroxyl groups of proteins are involved in hydrogen bonding 
with the solvent molecules (Creighton, 1991). 
The 90% change in the fluorescence (AF max) resulting from incubation 
with NaSCN for native a2M both at (X ex) 280 and 295 nm was reached far more rapidly 
than that of a2M-MeNH2 (Fig. 4.18 and 4.19). That attainment of AF max necessitates 
approximately twice the time for a2M-MeNH2 complex than for native a2M. This is a 
further indication of the enhanced interactions between the non-covalently associated 
subunits in the methylamine treated a2M. The methylamine induced enhancement in 
interaction between the dimers may be far more stronger in case of human a2M that 
requires a six-fold increased concentration of thiocyanate to induce a similar rates of 
changes in fluorescence comparable to the native a2M (Shanbhag et al., 1997). The 
difference is evidently related to the fact that only two thiol esters are cleaved on 
treatment of the buffalo a2M with methylamine while in case of human a2M all the four 
thiol esters are equally reactive to the methylamine treatment. It is also likely that the 
areas of contact between the disulphide bonded dimers are smaller dui to smaller 
dimensions of the buffalo a2M. It is however not clear if the two thiol esters cleaved in 
buffalo a2M are those in disulphide linked or non-covalently associated subunits. 
a2M is also a major zinc binding protein of human plasma (Parisi and Vallee, 
1970; Adham e( al., 1977). Equilibrium dialysis of the binding of "Zn by a2M at pH 7.9 
showed heterogenous binding which could be attributed to two classes of binding sites 
(Pratt and Pizzo, 1984). According to the Delain model (1988) the contact zone between 
two dimers may contain two strong Zri^* binding sites (Gettins and Cunningham, 1986). 
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The physiological zinc concentration in buffalo plasma as estimated by the 
method of Song et al. (1976) varies in the range of 18-20 {.iM, About 400-625 [ig Zn/g of 
purified protein was quantitiated in buffalo while about 320-770|ag of zinc has been 
reported per g of human a2M (Parisi and Vallee, 1970). 
The effect of zinc on the amidolytic activity of trypsin shown in Fig. 4.20 
indicates that trypsin binding activity does not depend on the presence of zinc in this 
protein, since removal of nearly all the zinc by EDTA results in no loss of trypsin binding 
activity. Increase in zinc concentration beyond 30 ^M results in marked loss of enzyme 
binding activity. Removal of unbound zinc from a2M against buffer containing EDTA 
did not restore its trypsin binding activity (Fig 4.20). 
The buffalo aiM exposed to either low or high zinc concentration responded to 
methylamine and Sepharose linked trypsin treatment as the native a2M (Fig 4.21) by 
undergoing the characterstic "slow" to "fast" transformation. 
Surprisingly, the aiM treated with 200 |iM zinc lacked the ability to protect 
trypsin against inhibition by SBTI (Fig. 4.20). Considering that bait region cleavage and 
accompanying gross conformational changes occur in the preparation treated with trypsin 
(Fig 4.20). The behaviour may be related to very rapid closure of the "Trap" aflter bait 
region cleavage without entrapment. Alternatively, small ai:eration in the interactions 
betweai the covalently associated dimers may restrict the steric protection to the inhibitor 
associated trypsin from reaction with SBTI. 
The intrinsic fluorescence spectra were clearly different for methylamine and 
proteinase treated buffalo a2M (Fig. 4.23). The emission maximum for native a2M is 
333 ran (at X ex 280 nm). Treatment of native a2M with Sepharose-linked trypsin caused 
a drastic decrease in fluorescence intensity with a small red shif!. Exposure of aromatic 
amino acids to a polar environment results in a decrease in fluorescense intensity 
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(Friedfelder, 1984). Methylamine causes 3nm blue shift with slight enhancement in 
fluorescence suggesting of burial of aromatic residues inside the protein. These findings 
clearly suggests that the conformational alteration accompanying trypsin and 
methylamine treatments are remarkably different in buffalo a2M. The emission 
maximum for native a2M at (X, ex) 295 nm was observed at 339 nm (Fig. 4.24) which is 
characteristic for tryptophanyl fluorescence. Both methylamine and immobilized trypsin 
treated aiM showed 3 nm blue shift in the emission maximum (Fig. 4.24). Interestingly 
results from Fig. 4.23 and 4.24 indicate that while tryptophans may get buried in the 
hydrophobic environment whereas tyrosine are exposed to the solvent after trypsin or 
methylamine treatment. Trypsin treatment induced gross conformational changes in 
buffalo a2M as has been observed in case of human, bovine and equine a2M using 
fluorescence measurements (Bjork and Fish, 1982; Bjork et al., 1985; Motoshima et al., 
1988). The buffalo inhibitor however appears unique in that it exhibits decrease in 
fluorescence on trypsinization but other aMs showed enhancement. Use of Sepharose-
linked trypsin in the experiments eliminates the interference by the proteinase as this does 
not results in the entrapment of the former and leads to the formation of "empty closed 
trap" (Mirza and Saleemuddin, 1993). The principal difference between this study and 
those of Bjork et al. (1982; 1985) and Motoshima et al. (1988) is the use of soluble 
trypsin by the latter for inducing the conformational alterations. It is now well known that 
the entrapment of the challenging soluble proteinase in a2M results the observed 
alterations in fluorescence that may actually represent a combined contribution of the 
accompanying conformational alteration and those of the entrapped proteinase. The effect 
of mefliylamine on buffalo a2M was however marginal suggesting minimal 
conformational alterations as observed in case of the bovine and equine a2Ms (Bjork 
et al, 1985; Motoshima et al, 1988). 
Exposure to zinc yielded interesting alteration in buffalo a2M in response to the 
methylamine and trypsin. Pretreatment of the inhibitor with 30 i^M zinc resulted in no 
major altwation in the fluorescence behaviour (Fig. 4.25), while exposure to 200 ^M zinc 
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caused a 30% decrease in fluorescence intensity (Fig. 4.26). It may recalled that buffalo 
a2M exposed to 200 ^M zinc loses the ability to protect trypsin from SBTI inhibition 
although it undergoes the characteristic proteolysis and methylamine induced alteration 
(Fig. 4.20). 
The observed decrease in fluorescence intensity in reaction of a2M with 
Sepharose-linked trypsin may be related to movement of tryptophan and tyrosine in the 
proximity of ionized amino acids thereby resulting in the quenching of the fluorescence. 
However, it is also possible that tryptophans shift in a region of a protein where 
movement of the indole ring is hindered (Friedfelder, 1984). 
Significant change in shape and magnitude in circular dichroic spectra of a2M 
treated with methylamine and trypsin has been reported for human a2M (Bjork and 
Fish, 1982). For buffalo a2M, minimal alteration was observed with methylamine similar 
to bovine and equine a2M (Bjork et al, 1985; Motoshima et a/., 1988) whereas 
Sepharose-linked trypsin caused a sharp decrease in ellipticity with a change in the shape 
of the spectra (Fig. 4.27). 
The major difference between human and buffalo a2Ms lies in the behaviour 
after treatment with methylamine. Following the cleavage of thiol ester bond by 
methylamine, human a2M undt goes extensive conformational change that alters both 
the secondary and tertiary structure as well as the shape of the protein (Bjork and Fish, 
1982, Goniase/a/., I982;Dangotte/a/., 1983). 
The observed changes in the buffalo a2M circular dichroic spectra resulting from 
reaction with methylamine and Sepharose-linked trypsin was analyzed by the method of 
Chen et al. (1972). Reaction with trypsin decreased a2M a-helix content from 
approximately 9 to 4% whereas methylamine caused no change. Gonias et al. (1982) 
reported a decrease in a-helix of about 9-10% from 14% for human a2M . For all three 
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forms of a2M (native, methylamine and trypsin treated) the majority of the remaining 
may be P-ordercd and unordered siruciure (Bjoric and Fish, 1982). The circular dichoric 
spectrum of the 30^M zinc treated buffalo a2M on reaction with both methylamine and 
Sepharose-linked trypsin showed similar pattern as native aaM (Fig. 4.29). 
There was a loss of about 2% secondary structure of 200)iM zinc pretreated a2M. 
Methylamine treatment of zinc treated form resulted only marginal change in the spectra 
as compared to trypsin treatment that caused a very significant decrease in mean residue 
ellipticity as shown in Fig. 4.30. 
The near-U.V. circular dichroism spectral changes as displayed in Fig. 4.31 may 
not be the true representation of major conformational changes in the protein. The spectra 
indicate alterations in the immediate structural and electronic environment of the 
aromatic amino acid residue resulting from interaction with methylamine or proteinase 
with the inhibitor (Creighton, 1991). The mean residue rotation of a2M treated with 
Sepharose-linked trypsin is decreased indicating the presence of less ordered structure as 
compared to native and methylamine treated a2M (Fig. 4.31). 
In conclusion it has been shown that buffalo a2M inspite of its smaller dimensions 
exhibits majority of the characteristics features. Investigations of the zinc treated buffalo 
a2M suggests tha. in presence of high concentration of the cation the inhibitor retains 
several characteristics features but irreversibly looses the ability to entrap and protect the 
protease from large molecular weight inhibitors. 
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Summary 
5.0 SUMMARY 
Buffalo plasma a2M was purified io an apparent homogeniety by 
ammonium sulphate fractionation and gel filtration chromatography. The 
protein was purified 35- fold with an yield of about 61%. The molecular 
weight determined by gel filtration and SDS-PAGE was 660 KDa. SDS-
PAGE in presence of thiol reductant dissociated the protein into quarter 
subunits with a molecular weight of 165 KDa. The stokes radius of buffalo 
a2M calculated from gel filtration data was 85° A. 
The purified buffalo a2M migrated as a single band on 
polyacrylamide gel electrophoresis and showed an increased mobility after 
reaction with trypsin. Methylamine caused only a small change in 
electrophoretic mobility. Trypsinization of the methylamine treated 
preparation completed the transformation to the fast form. 
Studies of methylamine revealed that buffalo a2M has thiol esters of 
unequal reactivity. Two of the four thiol esters appeared recalcitrant to 
methylamine treatment. The carbohydrate composition of the purified 
protein was 7.8% dry weight of the molecule. The amino acid composition 
of buffalo a2M appeared typical of a2Ms except for the deficient in proline 
and aspartic acid and higher content of alanine. Buffalo a2M exhibited good 
immunological cross reactivity against human and goat a2M. 
Sodium thiocyanate at 1.2M or higher concentration dissociated the 
native buffalo a2M into half molecules consisting of two disulphide bonded 
subunits. Methylamine treatment rendered the molecule more resistant to 
dissociation than native ot2M. The observed flourescence change indicates 
that conformational alteration occurs gradually on exposure to sodiiun 
thiocyanate. 
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The physiological zinc concentration of buffalo plasma was about 
18-20 fiM. a2M pre-treated with upto 30fiM zinc retained most properties 
of native azM, while a2M treated with IQO^M zinc exhibited an irreversible 
loss in activity, although it displayed the characterstic proteolysis and 
methylamine induced alterations in electrophoretic mobility. 
Trypsin treatment resulted in a significant decrease in intrinsic 
fluorescence of buffalo ajM whereas methylamine caused only marginal 
alterations. The magnitude of conformational changes occurring on 
methylamine and trypsin treatment were markedly higher in case of the aaM 
pretreated with 200 i^M zinc. The changes in the CD spectrum of buffalo 
a2M were also very small on methylamine treatment whereas loss in 
ellipticity was remarkable on treatment with Sepharose-linked trypsin. 
Treatment of buffalo a2M with 200 |aM zinc resulted in significant 
alteration in the CD spectrum also after treatment with methylamine or 
trypsin. Prolonged incubation with high concentration of the metal ion 
caused the dissociation of a2M into half molecules. 
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